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ABSTRACT OF DISSERTATION
THE ROLES OF ORTHOPAEDIC PATHOLOGY AND GENETIC DETERMINANTS IN
EQUINE CERVICAL STENOTIC MYELOPATHY

Cervical stenotic myelopathy (CSM) is an important musculoskeletal and neurologic
disease of the horse. Clinical disease occurs due to malformations of the vertebrae
in the neck causing stenosis of the cervical vertebral canal and subsequent spinal
cord compression. The disease is multifactorial in nature, therefore a clearer
understanding of the etiology and pathogenesis of CSM will allow for improved
management and therapeutic practices. This thesis examines issues of equine CSM
diagnosis, skeletal tissue pathology, and inherited genetic determinants utilizing
advances in biomedical imaging technologies and equine genomics. Magnetic
resonance imaging (MRI) data provided a more complete assessment of the cervical
column through image acquisition in multiple planes. First, MRI was compared to
standing cervical radiographs for detection of stenosis. Using canal area or the cord
canal area ratio, MRI more accurately predicted sites of compression in CSM cases.
Secondly, articular process skeletal pathology localized on MRI was found to be
more frequent and severe in CSM horses compared to controls. In addition, lesions
were generalized throughout the cervical column and not limited to the spinal cord
compression sites. A subset of lesions identified on MRI was evaluated using microCT and histopathology. Osteochondrosis, osseous cyst-like structures, fibrous tissue
replacement of bone, and osteosclerosis were observed. These lesions support
likely developmental aberrations of vertebral bone and cartilage maturation with
secondary biomechanical influences. Bone cyst-like structures are a novel finding in
this disease. Finally, the long-standing question of the contribution of genetic
determinants to CSM was investigated using a genome wide association study
(GWAS). Multiple significant loci were identified supporting the influence of a
complex genetic trait in clinical disease. A simple Mendelian trait controlled by one
gene is unlikely given the detection of variants across multiple chromosomes. Major
contributions from this research include documentation of articular process bone
and cartilage pathology in horses with CSM, support for abnormal cervical vertebrae
development being an important contributing factor in the etiology and/or
pathogenesis of equine CSM, and evidence that multiple genetic loci contribute to
the CSM disease phenotype.
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Chapter 1
Literature Review Of Equine Cervical Stenotic Myelopathy
Summary
Cervical stenotic myelopathy (CSM) is a disease that affects both the

neurological and musculoskeletal systems of horses. A diagnosis of CSM often

carries a guarded to poor prognosis, making this a serious problem in regards to the
health of the horse. A further understanding of the etiology and pathogenesis is
needed for improved management and therapeutic practices. This chapter will

focus on what is known about the disease in regards to epidemiology, clinical signs,
and diagnosis, as well as associated vertebral and spinal cord pathology. Following
the review will be a discussion of the long-standing questions regarding the

pathogenesis of this disease. At the conclusion of the chapter is an overview of the
dissertation.

Introduction and Background
Cervical stenotic myelopathy is a neurologic disease characterized by

malformations of the cervical vertebrae that lead to narrowing of the cervical spinal
canal and subsequent compression of the spinal cord. This cord compression

manifests as clinical proprioceptive neurologic deficits. Compressive myelopathy

has been reported in horses, large breed dogs, and humans (Mayhew et al., 1978;

Dimock and Errington, 1939; Bland, 1987; da Costa et al., 2006). Specifically in the
horse, CSM is thought to be a multifactorial disease with high planes of nutrition,
1

increased growth rates, alterations in zinc and copper concentrations, and genetic

determinants involved in disease development (Nout and Reed, 2003). Although all
these factors are known or suspected to play a role, the exact etiology and/or

pathogenesis that lead to clinical disease are still somewhat unclear. Over time, CSM
has been associated with a variety of terms, each aiming to accurately describe the
disease. These include cervical vertebral malformation (CVM), cervical vertebral
compressive myelopathy (CVCM), cervical vertebral instability, cervical static

stenosis (CSS), Wobblers Syndrome, and cervical stenotic myelopathy (CSM). For
unity, the term cervical stenotic myelopathy, abbreviated CSM, will be used
throughout the thesis.

The first reports in the literature of CSM are sporadic. Early theories

suggested the neurologic incoordination observed in affected horses was the result
of a previous traumatic event (Dimock, 1950). Colloquial terms for CSM included,
“jinxed back” and “weak loin” in reference to the horse’s appearance (Dimock and

Errington, 1939). In the first comprehensive publication regarding CSM, the disease
was described as an “equine disease characterized by a bilateral incoordination of

the hind limbs…affected are called “wobblers”.” This work identified weaning as a
common time for the onset of clinical signs and breed depositions for the

Thoroughbred and Saddlebred. The most pertinent clinical sign was hind limb

ataxia with occasional fore limb involvement (Dimock and Errington, 1939).

Pathologic changes noted in this survey included abnormal stenosis of the cervical

canal, arthritis, cervical nerve compression, and degenerative changes of the spinal
cord on histology.

2

Epidemiology
The epidemiology of CSM has been investigated, allowing perspective on the

incidence and prevalence of this disease. A retrospective study examined the types
of neurologic diseases seen at the University of Kentucky Veterinary Diagnostic

Laboratory over a nearly 3-year period from 2000 to 2002. A total of 4,559 equine
necropsies were performed during this time. Of the total cases, 397 (8.7%) were

determined to be of neurological origin after gross and histopathologic evaluation.
Neurological cases were further categorized by etiology as follows:

infectious/inflammatory, neoplastic, congenital, degenerative, traumatic and

developmental. A total of 158 (39.7%) of the neurologic cases were categorized as
having a developmental etiology. CSM was the only disease in the developmental
category; therefore, almost 40% of all neurological cases seen in this time period
were a due to CSM (Williams, 2003). Although cases were limited to the central

Kentucky area, these data support CSM as a significant neurologic disease of the
horse.

In addition to the previously described epidemiologic survey, two other groups

have made efforts to examine the incidence and prevalence of CSM cases in the

horse population. Incidence assesses the number of new cases over a given time
period, whereas prevalence measures cases at a defined point in time. One

approach examined clinical records from multiple Thoroughbred breeding farms in
Europe and the US over a 6-year period. The overall disease incidence was

3

determined to be 1.3% (Oswald et al., 2010). Previous to this report, an estimated
of 2% was published (Rooney, 1969).
Signalment and Etiologic Factors

Multiple publications have contributed to a strong knowledge base regarding the

signalment of CSM horses, specifically gender, breed, and age. A well-documented
gender bias of male over females is established in the literature. Gender ratios of
affected males to females range from 3:1-23:1 (Dimock, 1950; Steel et al., 1959;
Falco et al., 1976; Levine et al., 2007; Levine et al., 2008; Levine et al., 2010). A
retrospective study examining possible breed associations with CSM found

Thoroughbreds, Warmbloods, and Tennessee Walking Horses more likely to

develop the disease as compared to other breeds (Levine et al., 2007; Levine et al.,

2008; Levine et al., 2010). In regards to age, historically CSM has been thought of as
a disease of young horses often falling under the categorization of developmental

bone diseases. Various studies have identified the mean ages of CSM horses as less
than 2 years (Dimock and Errington, 1939; Mayhew, 1978; Levine et al., 2008;

Levine et al., 2010). Recent retrospective studies have identified CSM developing in

older horses. That being said, odds ratios still indicate that younger horses between
6 months and 7 years of age are more likely to develop the disease (Levine et al.,
2007; Levine et al., 2008).

CSM is a multifactorial disease with environmental and possibly heritable

components (Mayhew, 1978; Falco et al., 1976; Mayhew et al., 1993). As previously
stated, high planes of nutrition, increased growth rates, alterations in zinc and
4

copper concentrations, and possibly genetic determinants play a role in disease
development. The relationship between nutrition and skeletal growth and

maturation is established in multiple species (Kronfeld et al., 1990). It has been
noted that often horses with CSM are larger than age matched pasture mates.

Commonly the disparity in size can be attributed to changes in feed to promote

growth and maturation for performance, competition, or commercial reasons. An

additional report suggested horses with a heavier head and longer neck could result
in predisposition to CSM (Rooney, 1969).

The role of genetic determinants in the development of CSM is a long-

standing question. Initial support for a genetic influence came from a pedigree
analysis that suggested a possible recessive transmission in the Thoroughbred

(Dimock, 1950). In contrast, a later pedigree study examined the disease in British

Thoroughbreds and did not find evidence for genetic influences (Falco et al., 1976).
A breeding study crossed dams (n=12) and sires (n=2), with a confirmed clinical

diagnosis of CSM, and followed the progeny for approximately one year (Wagner et

al., 1985). Crossing a CSM horse with a CSM horse did not produce the disease in

the offspring during their first year of life. Interestingly though, the foals did have
evidence of other developmental orthopaedic diseases such as osteochondrosis,
contracted tendons, and physitis, indicating aberrations in cartilage and bone

maturation. Finally, there is strong anecdotal evidence in families across breeds for
possible heritability. Therefore, the exact role of genetic determinants in the
development of CSM is still unresolved.

5

Clinical Presentation and Diagnosis
CSM horses present with neurologic proprioceptive deficits due to cervical

spinal cord compression. Most commonly, the hind limb ataxia is more pronounced
than the fore limb ataxia. Typically, the ataxia is symmetrical in nature with regard
to right and left sides of the horse. Situations in which the ataxia is asymmetrical
can result from alterations in the size or spatial positioning of the articular

processes which causes compression of the lateral spinal cord and nerve roots

(Moore et al., 1992). The anatomic arrangement of nerve tracts in the spinal cord

explains the distribution of the ataxia. The dorsal spinocerebellar tracts that control
proprioception in the hind limbs are located more superficially than the

proprioceptive tracts for the forelimbs (de la Hunta, 1983) (Figure 1.1). Therefore

when compression occurs, the dorsal spinocerebellar tracts are the first nerves

affected leading to development of higher grade of ataxia in the hindlimbs than the
fore limbs.

Figure 1.1: Distribution of the spinocerebellar tracts in the spinal cord. The
spinocerebellar tracts are located on the lateral aspect of the spinal cord. The tracts
for the pelvic limbs are superficial to the thoracic limbs. (Nout and Reed, 2003).
6

Diagnosis of this disease is focused on a thorough neurologic examination as

well as radiographic imaging studies of the cervical column. Neurologic deficits are

graded on a scale of 0-5, with 0 being normal and 5 indicating recumbency (Mayhew,
1978). As mentioned previously, CSM horses often present with a bilateral
symmetrical hind limb ataxia, with the forelimbs less severely affected.

Identification of this type of ataxia helps to differentiate CSM from other equine

neurologic diseases such as viral encephalitidies (Equine herpesvirus-1, Eastern

Equine encephalitis, Western equine encephalitis, Venezuelan equine encephalitis,
West Nile Virus, and rabies), protozoal disease (Equine protozoal

myeloencephalitis), trauma, or bacterial causes of encephalomyelitis. Deficits of the
cranial nerves are typically absent with cervical stenotic myelopathy. In addition to

the distribution of the ataxia, evaluation of the cerebral spinal fluid (CSF) can help to
rule in or rule out infectious etiologies of neurologic disease.

Findings from multiple investigators have established thresholds for

identification of vertebral canal stenosis on both standing cervical radiographs and
myelograms. Initially, detection of vertebral stenosis was done with semi-

quantitative methods (Mayhew et al., 1993). A radiographic score was assigned

based on assessment of the following parameters: stenosis of the vertebral canal,

caudal extension of the dorsal lamina, angular fixation, enlarged vertebral physes,
delayed bone ossification, and degenerative joint disease. This method was

evaluated in a survey of 132 Thoroughbred foals and found to accurately predict
disease in horses up to one year of age. A quantitative method evaluating the

absolute minimal sagittal diameter of the vertebral canal on standing cervical
7

radiographs was found to have a high sensitivity and specificity for disease

diagnosis (Mayhew, 1978). Subsequent to this work, radiographic intravertebral

thresholds or minimal sagittal diameter (MSD) ratios for identification of stenosis
for specific vertebral sites were introduced (Moore et al., 1994). The ratio

addresses variability associated with radiographic magnification and animal size

(Hudson and Mayhew, 2005). The vertebral canal height divided by the height of

the vertebral body determines the intravertebral ratio (Figure 1.2). Established

intravertebral thresholds for each vertebrae are as follows: C2-3, C3-4, C4-5 < 0.50;
C5-6 < 0.52; C6-7 < 0.56. Therefore, a radiographic ratio less than the established
value indicate presumptive stenosis at a vertebral site. The sensitivity and

specificity of this method was greater than 89% at each vertebral site. While the

MSD ratio evaluates the intravertebral measurements, a method has recently been
developed to assess stenosis between vertebrae (Hahn et al., 2008). Using the

smallest diameter between the dorsal lamina and vertebral body of two adjacent

vertebrae and dividing it by the height of the vertebral body gives the intervertebral
minimal sagittal diameter ratio (Figure 1.2). A cut off value of <0.485 is suggested
for identification of stenosis.

8

a
d

Figure 1.2: Two adjacent vertebrae in the sagittal plane for intravertebral and
intervertebral ratio measurements. The intravertebral ratio is composed of the
vertebral canal height at the cranial or caudal end of the vertebrae (line “a”) divided
by vertebral body height (line “d”). Vertebral canal height (lines “b” or “c”), using
the smaller of the two, divided by vertebral body height (line “d”) gives the
intervertebral ratio (Adapted from Hahn et al., 2007).
In addition to standing cervical radiographs, other diagnostic imaging

techniques are available. Cervical myelography is considered the best antemortem
clinical diagnostic for identification of vertebral canal stenosis in the horse.

(Rantanen et al., 1981; Papageorges et al., 1987) In contrast to the non-invasive
nature of cervical plain films, myelography requires anesthesia for injection of a

radio-opaque dye into the subarachnoid space for delineation of the cervical spinal
cord on radiographic images. The neck is then manipulated into a variety of

positions (neutral, flexed, and extended). In each of these positions, radiographs are
evaluated for attenuation of the dorsal and/or ventral dye column, suggesting
compression of the spinal cord at a particular vertebral site(s) (Figure 1.3).
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Figure 1.3: Cervical myelogram in the neutral position. The red line is located at a
point with normal presence of the dorsal and ventral dye column (no compression).
At the yellow line, however, there is attenuation and loss of the dorsal and ventral
dye column suggestive of cord compression.
Decision criteria for confident detection of spinal cord compression on

myelography have been put forth in the literature (Van Biervliet et al., 2004;

Mayhew et al., 1978; Nyland et al., 1980; Nixon et al., 1982; Papageorges et al., 1987;

Neuwirth et al., 1992). Such criteria include a dorsal myelographic column of <2mm
at a vertebral site or narrowing of the dorsal and/or ventral dye columns by > 50%
as compared to the cranial vertebral site. Each have a varied ability to confidently
identify spinal cord compression associated with vertebral canal stenosis. van

Biervliet and co-authors found a 20% reduction in the dural diameter in the flexed

position at C6-7 to be highly sensitive and specific for cord compression due to CSM

(van Biervliet et al., 2004). Therefore, when evaluating the cervical column for

vertebral canal stenosis anatomical site, position (normal, flexed, extended), and
threshold criteria should be taken into consideration.

10

Disease Categorization
Based on myelographic assessment, compression can be classified as

dynamic or static. Dynamic compression occurs when attenuation of the dye

column happens only with the neck in the flexed or extended position. Often,

dynamic compression is seen in the mid cervical region, which encompasses the
third to the fifth vertebrae. On the other hand, if dye column attenuation is

observed regardless of neck position, then compression is categorized as static.

Typically this type of compression is seen in the caudal cervical column from the
fifth to the seventh vertebrae (Mayhew, 1999).

Consideration of the presence of specific gross pathologic lesions in the context

of signalment lead to a classification system of Type 1 and Type 2 cervical vertebral
malformation (CVM) (Mayhew, 1999). Features of type 1 CVM include the

following: age of onset from weaning until 2 years, static or dynamic stenosis,

pathologic changes of the articular processes such as osteochondrosis, kyphosis or

subluxation due to vertebral body malalignment, vertebral body physitis, and caudal
extension of the dorsal lamina into the intervertebral space. The lesions and

presentation of Type 1 CVM suggest a developmental aberration leading to the

described vertebral malformations. In contrast, Type 2 CVM typically affects older
horses. Vertebral lesions include osteoarthritic and degenerative changes of the
articular processes. Osteophytes and thickening of the articular soft tissues is

observed along with synovial cysts. Further descriptions of the vertebral changes
mentioned here is in the CSM pathology section of this chapter.
11

Treatment and Management
Several management and treatment options are available after a diagnosis of

CSM has been made. Selecting an appropriate option is dependent on the age of the
horse, number of sites of compression, chronicity of clinical signs, and financial

resources. Medical management of the disease includes reducing inflammation
from the repeated compression of the spinal cord. Routine anti-inflammatory

medications including non-steroidal anti-inflammatory drugs (NSAIDS), such as

flunixin meglumine, and corticosteroids are used in moderate to severe cases (Nout
et al., 2003).

Another focus of medical management is slowing the growth rate in young

horses, via a restricted diet to allow for bone remodeling (Donawick et al., 1989;
Donawick et al., 1993; Kronfeld et al., 1990). The impact of protein and energy

restriction in young horses with either suspected or confirmed neurologic and/or
radiographic deficits consistent with CSM has been investigated (Donawick et al.,

1989). In addition to diet restriction, reduced exercised was also included. The diet
comprised 65-75% of the recommended energy and protein content,

supplementation of copper and zinc at 2 times and 3.5 times the recommended NRC
level respectively, and access to hay. Conclusions from this study were that,

although the horses became quite thin, the dietary restrictions slowed growth rates
to allow remodeling of the vertebrae for sufficient space to negate spinal cord

compression. Since this study, other “paced” nutritional plans have been developed
which reduce energy and protein intake without the dramatic weight loss (S. Reed,
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personal communication). Use of the “paced” diet and exercise restriction is most
effective in horses under one year of age when maximal growth is occurring.

In situations where nutritional management is not sufficient, surgical options are

available, specifically cervical vertebral interbody fusion or dorsal laminectomy.
The surgery aims to prevent further spinal cord damage by stabilizing the

intervertebral joint and relieving cord compression. A retrospective survey over a
9-year period found that 77% of CSM who underwent surgery had some level of

neurologic improvement. Forty-three percent of horses returned to some sort of
athletic function (Moore et al., 1993). It was also reported in this study that the

number of compression sites did not have an effect on the post surgical outcome.
Cervical Vertebral Anatomy

Before describing the pathologic vertebral changes that have been associated

with equine CSM, a brief review of normal vertebral anatomy will be summarized.

Seven vertebrae make up the cervical column. Vertebrae are considered irregular

bones due to their shape. Other bone categories are long, flat, sesamoid, and short.

The vertebral spinal canal is the space occupied by the spinal cord. Vertebral arches
(pedicles) border the spinal canal on either side. The dorsal lamina forms the roof

of the canal and the vertebral body comprises the floor of the canal. Articular
processes are located on the dorsal aspect of the vertebrae (Figure 1.4).
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Figure 1.4: Images of cervical vertebral anatomy. The image on the left is a
schematic of a single cervical vertebra in the transverse plane. A- articular process;
B- vertebral canal; C- vertebral body; D- vertebral arch; E- transverse process; Fdorsal lamina; G- spinous process (Whitwell and Dyson, 1987). On the right, is a
photograph of the cervical column from C2-C7 in the sagittal plane.
There is a natural narrowing of the vertebral canal in the mid cervical region.

Epiphyseal plates are located at the cranial and caudal aspect of each vertebral body.
The cranial physis typically closes around 2 years of age in a ventral to dorsal

direction. In contrast, the caudal physis remains open until 4-5 years of age and

closes in a dorsal to ventral direction (Whitwell and Dyson, 1987). Cervical spinal
nerves exit the vertebral canal through the intervertebral foramen. The second
through the seventh cervical vertebrae have articular processes located on the

dorsal aspect. The first cervical vertebra, commonly known as the atlas, does not

have articular processes. The second vertebra, called the axis, only has 2 articular
processes, left and right, located on the caudal aspect of the vertebrae. Whereas

cervical vertebrae 3 through 7 have articular processes located on the left and right

side in both the cranial and caudal positions. The articular processes articulate with
the same structure of the adjacent vertebrae in the cranial or caudal direction
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forming synovial joints. The articular process joints function to connect the
individual vertebrae together forming the cervical vertebral column. Other

anatomic structures that stabilize the column include the following: the ligamentum
flavum, which connects dorsal laminas of adjacent vertebrae, fibrous disc material
between each vertebral body, and a complex arrangement of skeletal muscle
attachments.

CSM Pathology
Spinal Cord
There are characteristic histopathologic lesions that indicate compressive injury

to the spinal cord and are visualized in CSM cases. In the white matter, Wallerian
degeneration with the varying degrees of demyelination, presence of gitter cells,

dilated myelin sheaths, and spheroids (swollen axons) are consistent with spinal

cord compression (Figure 1.5). In chronic cases, perivascular fibrosis, motor neuron
loss, astrocytosis, and microglial scars are observed. (Summers et al., 1995).
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Figure 1.5: Histopathologic sections of the white matter of the spinal cord. The
image on the left is normal white matter at 2X magnification. The spinal cord on the
right is from a CSM horse at 10X magnification. Dilated myelin sheaths (thick
arrows), gitter cells (thin arrows), and spheroids (circle) are consistent with
compressive spinal cord injury seen in CSM.
Distribution of the lesions within the funiculi of the white matter aids in

lesion localization. Pathologic changes are visualized in the dorsal, lateral, and
superficial funiculi at the compression site. The dorsal and superficial lateral

funiculi, which contain the ascending nerve tracts, are affected cranial to the site of
compression, whereas the descending nerve tracts in the ventral and the deep

portion of the lateral funiculi are affected caudal to the site of compression (Figure
1.6).
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Figure 1.6: Schematic of lesion localization in the spinal cord. Black dots indicate
distribution of Wallerian degeneration (Mayhew, 1978).
Vertebral Body
The vertebral body can contribute to compression in several ways.

Narrowing of the vertebral canal can occur from dorsal deviation of the vertebral

body due to subluxation (Figure 1.7). Also, flaring of the caudal epiphysis results in
a focal decrease in canal height. Histopathological changes in the vertebral body

include increased bone known as osteosclerosis, mainly in the metaphysis, which
leads to distortion of epiphyseal plates. Chondronecrosis, osteonecrosis and

retained cartilage cores have been reported in the vertebral body as well (Mayhew
et al., 1978).
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Figure 1.7: Sagittal view of the cervical vertebral column demonstrating vertebral
body subluxation. There is upward deviation of the vertebral body into the canal
space (arrow). The spinal cord has been removed (Mayhew, 1999).
Articular Processes
The role of the articular processes in vertebral canal stenosis has been the

focus of multiple investigations. A variety of lesions have been reported including
degenerative joint disease, subchondral osteosclerosis, osteochondrosis, synovial
cysts, and thickening of the joint capsule. Similar to the vertebral bodies,

osteonecrosis, chondronecrosis, retained cartilage cores have been observed on

histopathology (Mayhew et al., 1978; Trostle et al., 1993; Stewart et al., 1991; Fisher
et al., 1981). Examples of gross articular process pathology are described in figure
1.8.
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Figure 1.8: Normal and gross pathology of the articular processes associated with
cervical stenotic myelopathy. The left picture is an articular process (formalin
fixed) from a control horse. The articular surface is smooth, and white with an oval
shape. The middle image (formalin fixed tissue) demonstrates degenerative or
arthritic changes including cartilage loss, dull and grey discoloration, and fibrillation
(yellow arrows). Also, the synovium is moderately thickened (thick arrow). The
right image (unfixed tissue) is an articular process with osteochondrosis. This
lesion is characterized by invaginations of the cartilage (black arrow).
Osteochondrosis is a developmental orthopaedic disease associated with a

failure of normal endochondral ossification in cartilage and bone maturation.

Articular process osteochondrosis in the context of CSM has been investigated as

well. It was found that although the frequency of articular process osteochondrosis
did not differ between CSM and controls, the severity of osteochondrosis did.

However both the frequency and severity of osteochondrosis in the appendicular
skeleton was greater in CSM horses (Stewart et al., 1991).

Alterations in the size and spatial orientation of the articular processes

impact the space available in the vertebral canal. Recently, the anatomy of the
articular process joint with relationship to the spinal cord in clinically normal

horses was evaluated with CT. The articular process joints were distended with
contrast media and the anatomy evaluated. Distention caused dorsolateral
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extension of the articular process joint into the vertebral canal. The authors

concluded that in the absence of pathologic changes distention of the articular

process joint was not sufficient to cause compression. However, it was speculated
that in the presence of pathologic changes in regards to size or spatial orientation,

joint space effusion could lead to compression (Claridge et al., 2010). Finally, earlier
work identified that malformations of the articular process joints caused lateral

compression of the spinal cord and peripheral nerve roots exiting the intervertebral
foramen (Moore et al., 1992).

Dorsal Lamina and Ligamentum Flavum
Changes to the dorsal lamina and ligamentum flavum have been described

primarily in the caudal cervical column, often observed as static cervical stenosis.
On gross examination, both the dorsal lamina and ligamentum flavum can be

thickened in CSM horses. The most common histopathologic change in the dorsal

lamina is osteosclerosis with retained cartilage also observed (Mayhew et al., 1978;
Powers et al., 1986). Fibrocartilage is observed at the insertion of the ligamentum
flavum at the dorsal lamina. Proliferation of fibrovascular tissue is also seen
scattered in the ligamentum flavum (Powers et al., 1986).
Important Knowledge Gaps

So far, this review has focused on what is known about CSM in regards to

epidemiology, signalment, diagnosis, treatment options, and pathology. Important

remaining questions include the exact etiology/pathogenesis that leads to the

development of CSM in the horse. Environmental factors are well documented. CSM
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is established as a multifactorial disease but the interplay of the factors, which leads
to clinical disease, is still unknown.

Two main theories have been developed to model CSM pathogenesis. The

first theory centers developmental abnormalities that lead to vertebral

malformations. Osteochondrosis, a developmental orthopaedic disease, has been
shown to occur with increased severity in CSM horses (Stewart et al., 1991).

Pathologic findings also support suppression of normal bone and cartilage turnover

and maturation (Mayhew, 1978). There is potential that these developmental issues
could begin in utero (Mayhew, 1999). The second theory proposes that CSM occurs

due to abnormal stresses on the cervical column leading to vertebral malformation.

Since the cervical vertebrae are still remodeling and developing up to approximately
5 years of age, they are more susceptible to biomechanical forces on the neck.

Thickening of the soft tissues, osteosclerosis of the dorsal lamina, and osteoarthritis

are supportive of the biomechanical model (Powers et al, 1986; Trostle et al., 1993).
Further investigation of the pathology associated with this disease could help
provide clarity to disease mechanisms for the clinical manifestation of CSM.

A related major knowledge gap is the role of genetic determinants as an

etiologic factor in disease susceptibility and/or development. Pedigree analyses and
anecdotal reports support a role of genetic determinants in CSM (Dimock, 1950;

Errington, 1938). On the other hand, a prospective breeding study minimizes the
likelihood of CSM being inherited as a single gene trait (Wagner et al., 1985).
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Powerful new scientific resources have been developed in recent years

through whole genome sequencing and related advances in the field of genomics

that provide new approaches to investigate potential genetic determinants of CSM.

In a large collaborative project that started in late 2006, the first horse genome was

sequenced to 6.8x coverage and assembled into the reference equine genome (Wade
et al., 2009). In addition to determining the primary nucleotide sequence of the
equine genome and specific chromosomal loci for functional elements such as

protein coding genes, this work led to the identification and characterization of

millions of genetic polymorphisms distributed throughout the equine genome. This
large number of polymorphic markers enables the potential for equine linkage

analyses, which can investigate co-segregation of genetic markers with hereditary
traits in families. Co-segregation studies can provide data to assess mode of

inheritance, identify genome regions or loci of importance, and help identify

potential candidate genes for a trait of interest. This family-based analysis is called

genome wide linkage study (GWLS).

Equine breeders, however, avoid matings that might produce hereditary

diseases. As a result, it is often difficult to assemble kindreds to study disease traits
using GWLS approaches. Furthermore, incomplete penetrance and complex

genetics will limit the effectiveness of family studies. Fortunately, the large number
of genetic markers allows an alternative approach based on distribution of genes

and the traits in closed breeding populations. Basically, individuals within a closed

breeding population will, on average, have the same chance of possessing any of the
genetic markers. However, if the population is divided into two groups based on a
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distinguishing characteristic, for example, whether or not they exhibit black-

pigmented hair, then any genetic markers that co-distribute with the trait will signal
that the trait is genetic and that a gene controlling that trait has a locus close to that
genetic marker. This approach is called a genome wide association study (GWAS).

GWAS can be very effective at uncovering individual genes regulating a trait based

on an unambiguous phenotype with a simple pattern of Mendelian inheritance. The
Extension locus alleles that regulate coat color are an example (McCue et al., 2012).

GWAS can also be applied, however, for investigating more complex genetic diseases
where the possibility exists of multiple variants that individually have a small

impact but collectively influence the phenotype of interest. Nucleotide sequence

variants distributed across the genome include single nucleotide polymorphisms
(SNPs), copy number variants (CNVs), microsatellites, and insertion/deletion

polymorphisms (INDELS) (Shafer and Hawkins, 1998). SNPs are variations in a

single base where as CNVs range in size from a couple of hundred bases to several
megabases in length. With the availability of these new genomic technologies and
reagents in the horse, reexamination of the role of genetic determinants in CSM is
justified.

Dissertation Overview and Objectives
CSM is one of the most common neurologic diseases in the horse. Depending

on the severity of clinical signs, euthanasia is often elected for humane and safety

reasons. Further investigation of remaining questions regarding the interaction of

etiologic factors and pathogenesis could help improve diagnostic, management, and
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treatment options of this important disease. The work presented in this thesis reinvestigates the etiology and pathogenesis of equine CSM using contemporary
imaging and genomic techniques.

Chapter 2: Comparison Of Standing Cervical Radiographs And Magnetic
Resonance Imaging For Evaluation Of Vertebral Canal Stenosis In Equine
Cervical Stenotic Myelopathy
The aim of the work described in Chapter 2 was to determine if magnetic

resonance imaging (MRI) allows for more accurate identification of cervical canal
stenosis as compared to lateral radiographs in CSM horses. The sensitivity and

specificity of lateral cervical radiographs to evaluate horses suspected of cervical
stenotic myelopathy (CSM) are limited by the assessment being restricted to the

sagittal plane. The ability of MRI to acquire images in multiple planes addresses this

issue. Radiographic cervical canal height measurements categorized by standard

minimal sagittal diameter (MSD) intravertebral and intervertebral ratios produced

several false positive and false negative canal stenosis determinations as defined by
spinal cord histopathology. Postmortem MRI measurements of canal area and cord
canal area ratio more accurately predicted sites of cord compression in CSM cases.

No differences in spinal cord measurements were observed when comparing CSM to
control horses, but each of the vertebral canal parameters achieved significance at

multiple sites. Results from this study support vertebral canal area and cord canal
area ratio as better parameters to predict the location of cervical canal stenosis
compared to only the sagittal plane of canal height. Therefore in the future,
development of MRI or computed tomography (CT) equipment capable of

evaluating the cervical column of adult horses will substantially enhance evaluation
24

of CSM patients. This chapter has been published in Equine Veterinary Journal
(Janes et al., 2013).

Chapter 3: Skeletal Pathology Of The Cervical Articular Processes In Equine
Cervical Stenotic Myelopathy
Experiments reported in chapter 3, focus on the characterization and

evaluation of articular process skeletal pathology associated with CSM. First,

identified articular process pathology was assessed both quantitatively in regards to
the number and location of lesions, and qualitatively in regards to severity. Subsets
of lesions were then structurally evaluated using micro-CT and routine

histopathology methods. It was found that lesions identified on MRI occurred at an
increased frequency and severity in CSM horses compared to controls. Also,

pathology was observed both at and away from the site of compression, supporting
a generalized problem of bone and cartilage maturation in the cervical column of
horses with CSM. Histologically, lesions included osteochondrosis, osseous cyst-

like structures, fibrous replacement of trabecular bone and the bone marrow, and

osteosclerosis. These lesions support a disease model with developmental skeletal

pathology as a primary issue with likely secondary biomechanical influences on the
articular processes leading to malformations.

Chapter 4: The Role Of Inherited Genetic Determinants In Equine Cervical
Stenotic Myelopathy
Chapter 4 re-examines the question of whether inherited genetic

determinants contribute in a substantial way to the susceptibility, etiology, and/or
pathogenesis of CSM. The experiments utilized equine genomic reagents and

protocols developed over the last several years. Carefully phenotyped CSM horses
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were compared to population data using the Equine SNP50 and Equine SNP 70 Bead
Chips for a genome wide association study (GWAS). In addition, a copy number

variant (CNV) assessment for identification of possible unique CNVs within a family
with increased disease prevalence was performed. Results of the GWAS identified
multiple significant loci composed of individual SNPs and haplotypes localized to
several chromosomes. Results of this study support a genetic role in the

development of CSM, but given that interesting regions were identified across the
genome, it is unlikely one or only a few major genes control the CSM phenotype.

Genetic contributions are likely more complex in nature with multiple loci involved
versus a simple Mendelian trait. This is consistent with the understanding that

clinical disease due to CSM is multifactorial in nature resulting from both genetic
and environmental variables.

Chapter 5: Reflections And Future Directions
The emphasis of this chapter will be a reflection on how experiments in this

thesis have contributed to reducing and/or refining the existing knowledge gaps in

our understanding of equine CSM. In addition, possible future studies based on the
results of this dissertation research are discussed.

Copyright © Jennifer Gail Janes 2014
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Chapter 2
Comparison Of Magnetic Resonance Imaging To Standing Cervical
Radiographs For Evaluation Of Vertebral Canal Stenosis In Equine Cervical
Stenotic Myelopathy.
Summary
Experiments in this chapter aimed to determine if magnetic resonance

imaging (MRI) allows for the more accurate identification of cervical spinal canal

stenosis as compared to lateral cervical radiographs in CSM horses. In addition, a
morphometric assessment of the vertebral canal was performed. Nineteen

Thoroughbred horses with CSM were compared to nine control Thoroughbreds.
Antemortem, the subjects had neurologic examinations and standing cervical

radiographs with sagittal ratios calculated from C3-C7. Intact cervical column MRI
scans and histologic examinations of the spinal cord were performed postmortem.
Morphometric parameters were measured on the vertebral canal, spinal cord, and
intervertebral foramen. Radiographic cervical canal height measurements

categorized by standard minimal sagittal diameter (MSD) intravertebral and
intervertebral ratios produced several false positive and false negative canal

stenosis determinations as defined by spinal cord histopathology. Postmortem MRI
measurements of canal area and cord canal area ratio more accurately predicted
sites of cord compression in CSM cases. Development of MRI or computed

tomography (CT) equipment capable of evaluating the cervical column of adult
horses will substantially enhance evaluation of CSM patients.
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Introduction
Cervical stenotic myelopathy (CSM, Wobbler Syndrome) is the result of

malformations of the cervical vertebrae, which cause stenosis of the vertebral canal
and compression of the spinal cord. Compressive myelopathy has been reported in
multiple species including horses, dogs, and humans (Mayhew, 1978; Dimock and
Errington, 1939; Bland, 1987; da Costa et al., 2006). CSM typically affects young
horses with an increased incidence in certain breeds, including Thoroughbreds,

Tennessee Walking Horses, Quarter Horses, and Warmbloods (Levine et al., 2008).

There is a well-documented gender ratio of males over females with reports ranging
from 3:1 up to 23:1 (Dimock, 1950; Falco et al., 1976). CSM is a multi-factorial

disease with genetics, high planes of nutrition, alterations in copper and zinc ratios,

rapid growth rates, and trauma thought to potentially play a role in the etiology and
pathogenesis.

Several groups of researchers have made important contributions to

antemortem diagnostic criteria of equine CSM using standing cervical lateral

radiographs and myelography (Mayhew et al., 1993; Moore et al., 1994; Hahn et al.,

2008; van Biervliet et al., 2004). Thresholds have been established using anatomical
measurements converted to intravertebral and intervertebral ratios to identify
presumptive areas of canal stenosis both at the intervertebral joint and within

vertebrae. With myelography, spinal cord compression can be visualized due to

attenuation of the dorsal and/or ventral contrast medium columns and interpreted
using published criteria for contrast medium column measurements. Compression
from the lateral aspect can also occur due to altered articular process shape, size,
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and spatial positioning. While both methods are important diagnostic aides, the

levels of false positives and false negatives remain problematic (Papageorges et al.,
1987). A factor contributing to this problem is the limitation of assessment to the

sagittal plane with lateral images. Changes in vertebral canal structure that might

lead to spinal cord compression are not restricted to reductions in the dimension of
dorsal-ventral height. Dorsal ventral radiographic views can be obtained as well,
but these views capture the articular processes and not the vertebral canal.

Therefore, a more complete view of the cervical column should improve diagnostic
assessment. The ability of magnetic resonance imaging (MRI) to evaluate a

structure of interest in multiple planes, as well as provide images of both soft tissues
and osseous structures in situ has the potential to overcome major limitations of
lateral radiographs when assessing equine patients for CSM. Given these

characteristics, this study was designed to test the hypothesis that MR imaging

provides a more rigorous assessment of the cervical vertebral canal as compared to

standing cervical radiographs in the horse. The objectives were to: 1) Compare the
ability of standing cervical radiographs and MRI to identify vertebral canal stenosis
in horses with CSM, and 2) Evaluate anatomic parameters of the vertebral canal,

spinal cord, and intervertebral foramen between control and CSM horses on MRI.
Materials and Methods
Animals
Horses utilized in the study were identified based on clinical history,

neurological assessment, cervical radiographs, and postmortem examination.
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Nineteen Thoroughbred horses with CSM (17 males, 2 female, age range 6-50

months with a mean of 18.1 months) were compared to nine control Thoroughbred
horses (6 males, 3 females, age range 9-67 months with a mean of 12.4 months).
Case and control horses were identified in collaboration with local veterinary
practitioners.

Clinical Examination
A neurologic examination was performed on each horse. A grading scale of

0-5, where 0 indicated no neurologic deficits and 5 indicated recumbency, was used
to classify the severity of clinical signs in the forelimbs and hind limbs (Mayhew,
1978). Standing lateral cervical radiography was obtained on all horses.

Radiographic images were measured and evaluated by a single blinded assessor.

Standard minimal sagittal diameter (MSD) intravertebral ratios (C2-C5 <0.50; C6

<0.52; C7 <0.56) (Moore et al., 1994) and intervertebral ratios (C2-C7<0.485) (Hahn
et al., 2008) were calculated from C2-C7 using Dicom Viewer software (eFilm

Workstation, Merge eMed, Chicago, Illinois). After antemortem clinical examination
and radiographs, owner-elected euthanasia was performed with an overdose of a
barbiturate following AVMA guidelines. Control horses had normal neurological
function, but were euthanized for other health-related reasons.
MRI Evaluation

Within 4 hours of euthanasia, the cervical spinal column was disarticulated in

the area of T3 to T5. Loss of cerebral spinal fluid was prevented by placing putty in
the vertebral canal at the disarticulation site. MR imaging was performed using a
1.5 Tesla magnet with a flexible surface receiver coil and spinal coil. The cervical
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column was imaged in cranial (C2-5) and caudal (C4-C7) sections. Sagittal,

transverse, and dorsal plane images using multiple sequences were acquired for
each section. The cervical column was evaluated in the neutral position.

Morphometric measurements were made by two independent assessors at the mid-

point of intervertebral joints for all parameters using an open source DICOM viewer
program (Osirix, Geneva, Switzerland) (Rosset et al., 2004). Measurements were as

follows: spinal cord height, spinal cord width, spinal cord circumference, spinal cord
area, vertebral canal height, vertebral canal width, vertebral canal circumference,

vertebral canal area, left intervertebral foramen height, right intervertebral foramen
height, and a ratio of the measured spinal cord area to vertebral canal area (Figure
2.1).
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Figure 2.1. Anatomical measurements of the vertebral canal and spinal cord using
proton density weighted MR images. Transverse plane images demonstrate spinal
cord and vertebral canal measurements at the midpoint of the cervical vertebral
articulation. A. Height and width measurements of the vertebral canal. B. Vertebral
canal area and circumference. C. Spinal cord height and width measurements. D.
Spinal cord area and circumference
Postmortem Evaluation
Postmortem examinations were performed by two assessors. The spinal

cord was removed from the vertebral column during disarticulation of intact

vertebrae. Intervertebral sites on the spinal cord were identified and marked

during disarticulation. The spinal cord was placed in 10% neutral buffered formalin
for fixation and processed routinely for histopathologic examination. Two to four
tissue sections were evaluated at each intervertebral site from C1-C2 to C6-C7.

Cervical stenotic myelopathy was confirmed by identifying compressive lesions
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microscopically at specific intervertebral sites based on the characteristic changes
of Wallerian degeneration with presence of gitter cells, dilated myelin sheaths,

spheroids (swollen axons), and fibrosis in appropriate dorsal, lateral, and ventral
funiculi within the white matter (Summers et al., 1995). Postmortem and
histopathologic examinations were also used to rule out other infectious,
inflammatory, or degenerative neurologic diseases of the spinal cord.
Experimental Group Classification:

Antemortem criteria for CSM horses included: 1) hind limb ataxia and

proprioceptive deficits, and 2) narrowing of the cervical canal on radiographs based
on intravertebral (C3-5 <0.50; C6 < 0.52; C7 <0.56) or intervertebral (<0.485)

minimal sagittal ratios. Histopathologic evidence of spinal cord compression on

postmortem examination was the definitive parameter used for a CSM diagnosis and
for specific site localization of disease (Table 2.1). Inclusion criteria for control

horses were an absence of neurologic deficits on the clinical examination and an
absence of compressive lesions on histologic examination of the spinal cord.

Site
C2-3
C3-4
C4-5
C5-6
C6-7

Standard MSD thresholds
for intravertebral sites,
and intervertebral sites
at 0.485 (radiographs)
Controls
CSM
1
6
3
16
2
11
1
16
5
15

Intra and
intervertebral
thresholds at 0.485
(radiographs)
Controls
CSM
0
5
1
12
1
4
0
10
3
5

Histopathological
evidence of spinal cord
compression
(postmortem)
Controls
CSM
0
1
0
13
0
7
0
11
0
6

Table 2.1. Study case categorizations based on different radiographic and
histological thresholds and assessments. Control (n=9) and CSM (n=19) horses
were classified at each individual intervertebral site. Some CSM horses were
narrowed at multiple sites accounting for variation in numbers in the CSM category.
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Statistical Analysis
Vertebral canal measurements at sites of spinal cord compression as

identified by histopathology in CSM horses were compared to control horses at the
same cervical position. Therefore, the total number of CSM samples analyzed at
each vertebral site was different (Table 2.1). Data measurements from all nine
controls were used at each vertebral site. Using the Anderson-Darling test,

morphometric parameter data were normally distributed. Data for morphometric
parameters were analyzed using a mixed statistical model that accounted for

variables of vertebral site, age, and gender using the PROC MIXED procedure in SAS
(SAS, Cary, NC). PROC LOGISTIC was used to determine if intravertebral and

intervertebral radiographic ratios, MRI canal area, and cord canal area ratios (CCAR)
could localize sites of histopathologic lesions on a vertebral site-by-site comparison.
To determine whether canal area and CCAR could predict a lesion regardless of

vertebral site, a generalized estimating equation accounting for repeated measures
was constructed with the additional variables of age, gender, site, and set.

Evaluation of the two MRI image assessors for concordance was done by

calculating an intraclass correlation coefficient for each morphometric parameter.

Coefficients, using a scale range of 0.00 to 1.00, were classified as follows: excellent
(>0.75), good (0.4-0.75), and poor (<0.4) (Shokuri and Edge 1996). The intraclass
correlation analysis was performed using the software program MedCalc for

Windows, version 12.5 (MedCalc Software, Ostend, Belgium). Significance was
defined at p<0.05.
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Results
Identification of False Positive and False Negative Cases
Based on the established radiographic MSD ratio and intervertebral

thresholds with reference to histopathologic assessment of spinal cord compression,
a subset of control and CSM horses were categorized as false positives or false

negatives (Table 2.1). Misclassifications based on MSD ratios were observed at each
vertebral site and are illustrated in figure 2.2 at the level of C4-5. Two control

horses were classified as having vertebral canal narrowing at C4-5, while three of
the CSM horses had vertebral canal ratios above thresholds used to indicate a

likelihood of stenosis. In contrast, using canal area determined from the MRI images,
control and CSM horses segregated more distinctly (Figure 2.2).
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Figure 2.2: Scatter plot of the MSD ratios from radiographs and canal area
measurements from MRI of horses with compressive lesions at C4-5. The left
ordinate is for the sagittal radiographic ratios with positions of the established
thresholds indicated. The right ordinate is for the MRI canal area data. Two control
horses (blue circles) have MSD ratios indicative of spinal cord compression, which
was not present on postmortem histology. Three CSM horses (red circles) fall above
the radiographic thresholds, even though spinal cord compression was confirmed
by postmortem histology. Canal area values for two false positive control and three
false negative CSM horses (blue and red diagonal lines respectively) cluster within
the appropriate groups.
Similar partitioning of CSM and control groups based on canal area and CCAR was
observed at the other cervical vertebral sites (Figures 2.3 and 2.4).
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Figure 2.3: Scatter plot of the MSD ratios from radiographs and canal area
measurements from MRI of horses with compressive lesions at the fourth, sixth, and
seventh cervical vertebrae.
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Figure 2.4: Scatter plot of the MSD ratios from radiographs and cord canal area ratio
(CCAR) from MRI of horses with compressive lesions at the fourth, fifth, sixth, and
seventh cervical vertebrae.
Anatomic Changes of the Cervical Vertebral Column on MRI
While no significant differences in spinal cord measurements on MRI were

observed, each of the vertebral canal parameters achieved significance at multiple
sites when comparing CSM to control horses (Table 2.2).
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Site

Number

Canal Height
(cm)

Canal Width
(cm)

Canal Circ. (cm)

Canal Area
2
(cm )

C2-3

Control (n=9)
CSM (n=1)
Control (n=9)
CSM (n=13)
Control (n=9)
CSM (n=7)
Control (n=9)
CSM (n=11)
Control (n=9)
CSM (n=6)

2.63±0.52
2.56
2.18 ± 0.30
1.92±0.28**†
2.14±0.28
1.75±0.28**
2.18±0.26
1.80±0.35**
2.37±0.41
1.85±0.46**

2.17±0.20
4.432
2.44±0.41
2.12±0.43**
2.59±0.35
2.26±0.41**
2.76±0.27
2.51±0.59*
3.14±0.53
2.69±0.55**

8.85±1.29
10.096
8.00±0.94
6.94±.96
8.10±0.98
6.75±0.74**
8.60±0.56
7.22±1.38**
9.77±01.14
8.20±1.48**†

5.65±1.31
7.419
4.62±0.97
3.49±0.95**†
4.70±0.90
3.21±0.66**
5.07±0.58
3.73±1.19**†
6.40±1.33
4.38±1.52**

C3-4
C4-5
C5-6
C6-7

Site

Number

L IV Foramen Height
(cm)

R IV Foramen Height
(cm)

Cord Area/ Canal Area
Ratio

C2-3

Control (n=9)
CSM (n=1)
Control (n=9)
CSM (n=13)
Control (n=9)
CSM (n=7)
Control (n=9)
CSM (n=11)
Control (n=9)
CSM (n=6)

0.76±0.15
1.136
0.88±0.17
0.66±0.23**
0.91±0.14
0.72±0.24**†
1.05±0.11
0.75±0.21**
1.18±0.18
0.73±0.30**

0.78±0.17
1.262
0.88±0.17
0.73±0.17**
0.95±0.17
0.74±0.30*
0.98±0.17
0.80±0.23**
1.20±0.23
0.80±0.30**†

0.21±0.07
0.148
0.28±0.07
0.33±0.08**†
0.25±0.05
0.37±0.08**†
0.26±0.03
0.36±0.09**†
0.25±0.05
0.38±0.10**†

C3-4
C4-5
C5-6
C6-7

Table 2.2: Comparison of vertebral measurements between control and CSM horses
on MRI. Data are presented as the means and standard deviations. CSM disease
status was based on postmortem histopathologic evaluation of the spinal cord.
*p<0.05; **p<0.01, however site C2-3 had only one CSM horse and could not be
statistically evaluated.
† indicates significant interaction of age;
Circ.=circumference; L IV= Left Intervertebral; R IV= Right Intervertebral
The ratio of spinal cord area to vertebral canal area was larger in the CSM group,

consistent with a decreased space within the vertebral canal for the spinal cord to

occupy. The intraclass correlation coefficient evaluating assessors ranged from 0.70
to 0.89, indicating good to excellent concordance for the morphometric parameter
assessment.
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MRI and Radiographic Assessment for Compression
CSM horses frequently demonstrated circumferential attenuation of cerebral

spinal fluid on transverse images suggestive of compression (Figure 2.5).

Figure 2.5: Transverse MR images showing the absence and presence of spinal cord
compression. The image on the left is at the level of C4-5. The spinal cord is round
with circumferential cerebral spinal fluid (CSF) (green arrows). From the same
horse, the image on the right is at the level of C5-6 and demonstrates a narrowed
canal area with ventral compression of the spinal cord, attenuated CSF, and
encroachment of the articular process joints (yellow arrows). Compression of the
spinal cord at C5-6 was confirmed on histologic examination.
Canal area and CCAR measured on MRI were evaluated for the ability to predict
compressive lesions in a site-by-site comparison. All vertebral sites achieved

statistical significance with canal area and CCAR (p < 0.05) as the predictor of a

compressive lesion at a particular vertebral site. In contrast, for the radiographic

parameters, lesion site significance (p <0.05) was limited to C3-4 and C5-6 for both

intravertebral and intervertebral ratios. The MRI canal area parameter (p <0.05)

was able to predict compressive lesions across the entire sample set regardless of
vertebral site. CCAR was also significant for predicting compressive lesions.
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Discussion
The primary objective of this study was to compare standing cervical

radiographs to MRI for the evaluation of cervical vertebral canal stenosis in horses.

MRI allows examination of both soft tissue and skeletal structures in situ in multiple
planes, which addresses the current limitation of only evaluating the sagittal plane
when using standing radiography. The ability to assess the cervical column in a

transverse plane allows for the application of additional anatomic parameters and a

more rigorous evaluation of the variability in cervical vertebral structure, which can
cause stenosis in diseased cases. The results indicate that MRI is superior as an

imaging tool for the identification of vertebral canal narrowing in horses with CSM

when compared to standing cervical radiographs. This finding is consistent with the
results of a study that examined the use of MRI to assess canine cervical vertebral

pathology. Comparison of myelography and MRI techniques in Doberman Pinchers
found that MRI had a higher degree of accuracy for identifying the site and severity

of spinal cord compression (da Costa et al., 2006). In the current study, spinal cord

compression of CSM horses frequently demonstrated circumferential attenuation of
cerebral spinal fluid on transverse images (Figure 2.5). Significant differences were
seen in anatomical measurements of the vertebral canal (Table 2.2), but not the

spinal cord itself. This finding is consistent with a pathogenesis that starts with

skeletal malformations resulting in compression of the cervical spinal cord (Stewart
et al., 1991; Mayhew, 1978).

Interestingly, multiple control horses had at least one area with radiographic

measurements suggestive of cervical spinal canal narrowing on standing lateral
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views, yet no neurological deficits on clinical examination or histopathologic

evidence of spinal cord compression. Figure 2.2 is a graphic comparison of the

corresponding canal areas and standard MSD intravertebral ratios for all horses in
the study with compressive lesions at C4-5 and the controls. Using either the

standard MSD or 0.485 thresholds for cervical radiography at intravertebral and

intervertebral sites, two controls fall below these lines and are false positives given
their absence of compressive lesions on histology. In addition, three horses with
cord compression confirmed by histology have values above these thresholds,

making them false negatives on radiographs. Canal area measurements obtained

from MR images at the same sites, however, segregate more accurately. As a two-

dimensional transverse measurement, canal area accounts for variability not only in
canal height but other directions as well. Sagittal plane views on lateral cervical

radiographs are limited to assessment of canal height in the dorsal-ventral direction

only. Variation in vertebral canal shape may provide adequate room for the spinal
cord despite a low canal height. This is a possible explanation for the subset of

horses with a suggestion of compression on lateral radiographs, yet an absence of

clinical or pathologic lesions consistent with CSM. While some ambiguity remains,
as represented by an overlap of canal area and CCAR measurements between CSM

and control horses at various vertebral sites (Figures 2.3 and 2.4), the results of this
dataset indicate an improvement over lateral cervical radiographs.

Neck position is an additional opportunity for improving the accuracy of

diagnostic imaging. Myelograms have been used to demonstrate how cord

compression can be accentuated in flexion or extension in some cases (Nixon et al.,
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1982). This has lead to a description of lesions as dynamic if flexion or extension

accentuates the compression, or static if compression is evident regardless of neck
position. Dynamic lesions might also explain the apparent paradox of cord canal
area ratios being less than one at sites of compression in CSM horses. While the

mean values are significantly higher than the controls, measurements ranging from
0.33 – 0.38 cm2 still suggest adequate space for the spinal cord within the vertebral
canal. However, if the compression is position-dependent, then the true severity of

the stenosis may not be reflected in the CCAR with the neck in a neutral position.

There are also varying degrees in the severity of stenosis, and therefore the average
CCAR for the sample set does not reflect the gradient of stenosis observed in
individual cases.

Intervertebral foramen heights varied at different vertebral sites, but were

consistently smaller in CSM horses. This finding supports previous work in which

CSM horses were examined by computed tomography (CT) with lateral compression
of cervical spinal nerve roots due to malformations in the articular processes

(Moore et al., 1992). In this study as well, altered position of the articular processes
impacted intervertebral foramen height. Identification of significant differences

between CSM and control groups in regards to intervertebral foramen heights is
largely dependent on the spatial positioning and size of the articular processes.
As discussed above, the determination of canal area is a more accurate

assessment of canal size, but the ability to predict compressive lesions is the

important diagnostic issue. In contrast to intervertebral and intravertebral sagittal
ratios, canal area and CCAR were able to predict histopathologic compressive
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lesions regardless of vertebral site. Overall, vertebral canal area was smaller at sites
of compression identified by histologic examination as compared to the controls. In
the exceptions, where CSM canal areas segregated with canal area of controls, it is

felt this is largely due to the limitations of only the neutral position being evaluated
in this study. Therefore, in the future, canal area and CCAR could be developed as

morphometric parameters for antemortem assessment of Wobbler Syndrome in the
horse.

Age was found to have an influence on several morphometric parameters in

this study (Table 2.2). The growth plates of the vertebral endplates in the cervical

column do not close until 4-5 years of age. Horses included in the sample set were
up to 5.5 years of age; therefore, there is continued maturation of the vertebrae as

the result of normal growth patterns in the horse. These findings reflect the young
age of onset often seen in the development of CSM.

The current study was performed with a sample set of 19 CSM horses and 9

controls, yet was still able to detect significant differences between the two groups
of horses. Examination of more horses in future studies will provide additional

power for the establishment of threshold MRI criteria to predict the presence or

absence of stenosis, as is currently defined for the assessment of standing cervical
radiographs with the intravertebral and intervertebral minimal sagittal diameter
ratios. With an increased sample size, a receiver operating characteristic (ROC)

curve could be constructed for assessment of diagnostic accuracy and determination
of the sensitivity and specificity of the canal area parameter. Given the significance

of canal area and CCAR to identify specific sites of compression on postmortem MRI,
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it is felt these parameters could possibly provide an increased sensitivity and

specificity for identifying canal stenosis antemortem. This could have a strong

impact on site selection for cases undergoing review for surgical treatment. Further
investigation of the vertebral canal area and CCAR is necessary in regards to the

influence of position and establishment of intervertebral site-specific thresholds.
However, breed differences are likely to be important (Mitchell et al., 2012). All
horses evaluated in the current sample set, both cases and controls, were

Thoroughbreds with an age range of 6 months to 5.5 years. Absence of breed

variation likely contributed to the finding that canal area could accurately predicted
lesion site, in contrast to the earlier study. For this reason, CCAR or another ratio
parameter may prove to better accommodate breed and age variations than the
absolute measure of vertebral canal area.

Technology is continuing to advance in regards to both MRI and CT units.

Although the size of most adult equine patients currently precludes antemortem
assessment of the complete cervical column by MRI, large bore CT scanners may
permit imaging of the entire equine cervical vertebral column. It is feasible that

transverse plane vertebral column measurements could be obtained in this fashion
for clinical cases. The ability to image the cervical vertebral column in the

transverse plane and multiple neck positions will substantially enhance clinical
evaluation of CSM horses.

Copyright © Jennifer Gail Janes 2014
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Chapter 3
Skeletal Pathology Of The Cervical Articular Processes In Equine
Cervical Stenotic Myelopathy
Summary
Skeletal lesions in the articular processes of cervical vertebrae C2 – C7 were

compared between horses with cervical stenotic myelopathy (CSM n=19) and

controls (n=9). Lesions identified by magnetic resonance imaging (MRI) occurred

with an increased frequency and severity in CSM horses and were not limited to the
site of compression. Pathology involved both the articular cartilage and trabecular
bone, including osteochondrosis, osseous cyst-like structures, fibrous tissue

replacement of trabecular bone, and osteosclerosis. The identification of osseous
cyst-like structures is a novel finding. These lesions and their generalized

distribution indicate that developmental abnormalities of the cervical spine are
primary changes associated with equine CSM.
Introduction

Equine CSM is a multifactorial disease of the musculoskeletal system that

presents clinically with proprioceptive neurologic deficits that are worse in the

pelvic limbs. The disease is characterized by malformations of one or more cervical

vertebrae that lead to stenosis of the spinal canal, cord compression, and damage to

nerve tracts. Proposed etiologic factors include high planes of nutrition, accelerated
growth rates, altered ratios of copper and zinc, and inherited genetic determinants.
While much is known regarding signalment and clinical diagnosis, the exact

pathogenesis of CSM remains unclear and likely reflects more than one path to a
similar clinical presentation. Over the years, two theories have been proposed
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based on multiple studies. The developmental theory proposes an underlying

disorder of bone and cartilage tissue morphogenesis and maturation leading to

cervical vertebral malformations. The biomechanical theory, in contrast, advances a
process whereby abnormal mechanical stresses and forces on the cervical column
result in structural vertebral changes leading to canal stenosis.

Efforts put forth by multiple groups have contributed to a knowledge base

for aberrations in vertebral development associated with CSM. A comprehensive

examination of pathologic lesions (Mayhew et al., 1978) suggested abnormal bone
and cartilage maturation manifested as osteosclerosis and osteochondrosis.

Interestingly, lesions were also observed in the costochondral junction of the ribs

supporting a possible systemic bone and cartilage maturation issue. Further work

examined the frequency and severity of osteochondrosis in the articular processes
with comparison to the appendicular skeleton (Stewart et al., 1991), finding an

increased severity of osteochondritic lesions in both the axial and appendicular
skeleton of CSM horses. It has also been suggested that cervical malformations
could start as early as in utero (Mayhew, 1999).

On the other hand, there is support for a model of pathogenesis whereby

abnormal biomechanical forces lead to vertebral malformations and canal stenosis.

Maturation of equine vertebrae continues until approximately 5 years of age at

which point the vertebral body growth plates close (Whitwell and Dyson, 1987).

During this time and even following growth cessation, vertebrae are responsive to
biomechanical forces on the neck through Wolff’s Law and related variables of
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mechanical regulation (Wolff, 1986; Chen et al., 2010). Mechanical variables in the
form of strain, oscillation, and vibrations have been demonstrated to impact bone
morphology (Judex et al., 2009). Lesions consistent with abnormal forces on the
neck include degenerative changes of the articular processes, thickening of the

dorsal lamina, and hypertrophy of the ligamentum flavum (Powers et al., 1986;
Trostle et al., 1993).

The major knowledge gap(s) in regards to CSM pathogenesis is/are the

mechanism(s) by which these lesions develop and progress to clinically significant
spinal canal stenosis. The rapid development of imaging technologies allows for
examination of the cervical column in situ for pathologic lesions associated with
CSM. This study focuses on the articular processes, given that changes in their
shape, size, and spatial orientation frequently contributes to spinal cord
compression (Moore et al., 1992).

Experiments in this chapter aim to assess, both quantitatively and

qualitatively, cartilage and bone lesions observed by MRI in the articular processes
of CSM horses as compared to controls. A subset of representative lesions is then

further characterized with micro-CT and routine histopathology. Achieving a better

understanding of the distribution and types of lesions that occur within the articular
processes will lead to greater insight into the etiopathogenesis of CSM in the horse.
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Materials and Methods
Magnetic Resonance Imaging
Sample Acquisition

Horses identified for these experiments follow the criteria previously

outlined in chapter 2 of this thesis. Briefly, CSM horses (n=19) underwent

neurologic examinations and standing cervical radiographs. Postmortem, gross and
microscopic evaluation of the spinal cord was performed. Presence of a focal
compressive lesion was used as the criteria to confirm CSM and specific site

localization. All control horses (n=9) had an absence of clinical and postmortem

characteristics consistent with neurologic disease. Acquisition of MRI data from the
cervical column was performed within 4 hours of euthanasia. T2, PSFD, and STIR
images were obtained. Immediately following MRI, each vertebrae was

disarticulated intact from the cervical column and placed in 10% neutral buffered
formalin for fixation.

Articular Process Lesion Identification, Location Classification, and Severity Scale

Variations from expected MRI signal intensity were identified as perspective

lesions and classified as either superficial or deep based on anatomic location.

Superficial lesions involved the articular cartilage and/or subchondral bone with

possible extension into the trabecular bone. Lesions within an articular process that
did not involve the articular cartilage or subchondral bone were defined as deep.

Lesions were then assigned a grade of 0-3 based on a scale adapted from previous

work (Smith et al., 2012) and described below (Figure 3.1). Lesions were required
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to be present on a minimum of 2 of the 3 MRI image studies (PDFS, T2, STIR).

Superficial lesion scoring criteria: Involvement of the articular cartilage and/or the subchondral
bone and possible extension into the underlying trabecular bone.
Grade 0: Normal (no pathology detected)
Grade 1: Subtle irregularity of chondro-osseous margin with no involvement of
subchondral bone
Grade 2: Irregular chondro-osseous margin with subchondral bone defect of < 0.7cm in
either dimension
Grade 3: Irregular chondro-osseous margin with subchondral bone defect of > 0.7cm in
either dimension

Deep lesion scoring criteria: Trabecular bone involvement with no involvement of the articular
cartilage or subchondral bone.

Grade 0: Normal (no pathology detected)
Grade 1: Generalized mild signal alterations
Grade 2: Generalized moderate signal alteration or focal signal intensity changes < 1 cm
in any dimension
Grade 3: Generalized severe signal alterations or focal signal intensity changes > 1 cm in
any dimension

Figure 3.1: Summary of the superficial and deep lesion criteria and corresponding
severity grading scale.
Statistical Analysis

A generalized linear statistical model was used to determine if there were

significant differences in frequency of articular process lesions between CSM and
control groups. In this model, lesion count was regressed on group using the

Poisson regression (SAS, Cary, NC). For assessment of severity, a generalized linear

equation with a multinomial model to account for the grading scale of 0-3 was used.
Significance was defined as p <0.05.
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Structural Analyses of Articular Process Lesions
Sample Identification

A subset of samples from the above-described dataset was selected for

structural analyses. Four CSM horses with deep lesions and four CSM horses with
superficial lesions were chosen (Table 3.1). Control horses with an absence of

lesions on MRI were identified to match as best as possible for anatomical site,

gender, and age of the CSM horses. No horse was repeated within or across groups.
Articular process sites varied between groups. All lesions were assessed as a grade
2 or grade 3. Articular processes both at and away from the site of spinal cord

compression were included. The table below summarizes the signalment of the
groups. Articular processes were removed from the vertebrae for scanning.
Deep Lesions
CSM (n=4)

Control (n=4)

Site

Age

Gender

Age

Gender

Left caudal C5

11 months

Male

17 months

Male

13 months

Male

15 months

Male

Left cranial C6
Right cranial C6
Right cranial C7

6 months

18 months

Male
Male

10 months
23 months

Superficial Lesions
CSM (n=4)

Male
Male

Control (n=4)

Site

Age

Gender

Age

Gender

Left caudal C2

15 months

Male

17 months

Male

10 months

Female

9 months

Left cranial C4
Left caudal C6
Left cranial C7

20 months
50 months

Male

Female

22 months

Female

67 months

Female

Table 3.1: Signalment and articular process sites for structural analysis.
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Female

Micro-CT Image Acquisition and Visualization

A custom micro-CT scanner (150/225 Ffi-HR-CT, BIR, Lincolnshire, IL) with a

225kV X-ray source, 5μm focal spot, and image intensifier with a 1024 x 1024 pixel
digital camera was used. X-ray power settings were 135 KeV and 0.059 mA with a

distance of 703 mm from the x-ray source to the image detector (Voor et al., 2008).

The source to object distance was 177.5 mm. Scanning was performed in the offset

mode with the center of the tube 15 mm lateral to the center of the x-ray beam. The

articular process was placed in a radiolucent acrylic holder and scanned using a 360
degree-plus-fan-angle rotation. A total of 107 slices were captured per revolution

with each slice representing a thickness of 30 μm. The final reconstruction resulted
in image stacks of 2048 x 2048 pixels. Image stacks contained 30 μm voxels with a
16 bit gray scale..

Image stacks were imported into VGStudio Max for construction of 3D

models of the articular processes (v1.2.1, Volume Graphics, Heidelberg, Germany).
Regions of interest were identified based on localization from MRI data

demonstrating the lesions. The cranial or caudal most point of the articular margin

was identified on MR and used as the starting point for measurements to localize the
lesion.

Trabecular Bone Volume Measurement

Images stacks of 200 slice increments were imported into Image J (Abramoff

et al., 2004) at 25% of the total image size. Coordinates were acquired for image

stack borders for trabecular bone volume measurements in a custom bone volume
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analysis program using MATLAB (v7.1, The Mathworks, Natick, MA). Trabecular
bone volume was calculated as percentage of total volume.
Statistical Analysis

A generalized linear model was used to determine if there were significant

differences in trabecular bone volume of the articular processes identified in CSM

horses with deep lesions compared to controls, CSM horses with superficial lesions
compared to controls, and then a combination of the deep and superficial groups
compared to controls (SAS, Cary, NC). Significance was defined as p <0.05.

Histopathologic Assessment of Articular Process Lesions
Sample Identification

A representative subset of articular process lesions identified on MRI from

both CSM and control horses were assessed histologically. All lesions imaged with
micro-CT were included in this study. The figure below summarizes the sample

numbers and distribution of grades within each group (Figure 3.2). No horses were
repeated within a grade or a group, although in some cases independent lesions
from the same horse were used across groups.
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Figure 3.2: Number of samples in each grade category analyzed histologically.
Grades are variable within the mixed group, as often the superficial and deep
components would qualify for different grades based on severity. Control horses
had a very limited number of deep lesions available for assessment.
Histopathologic Processing and Evaluation

Transverse sections of the region of interest from the articular processes

were excised using a scroll saw based on MRI localization and measurements.

Sections were decalcified using Decalcifier Rapid S (Labsco), embedded in paraffin,
and 5 μm sections processed routinely for hematoxylin and eosin staining. Slides
were examined for histopathologic changes.
Results
MRI Lesion Frequency
Lesions identified on MRI studies were evaluated for significant differences

in frequency between CSM and control horses. Analyses compared anatomic

localization (superficial or deep), compression site or noncompression site, as well
as the entire cervical column. Significant differences were identified on frequency

comparisons using all lesions at all sites, all superficial lesions, all deep lesions, and
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deep lesions at noncompression sites (Figure 3.3). Within the group of CSM horses,
there were individuals with compression and others without compression at each
vertebral site. Therefore, the corresponding control dataset used for comparison
are the same within All Lesion, Superficial Lesion, and Deep Lesion categories.

Figure 3.3: Articular process lesion frequency distribution. Compression and
noncompression designations refer to anatomical locations of stenosis for the CSM
horses, with comparison to the corresponding anatomical sites from control horses.
By definition, control horses have no cervical spinal cord compression sites. Data
are represented as average number of lesions per horse in each group. * p value
<0.01.
Lesion Severity Analysis
In addition to the number of articular process lesions, severity of the lesions

was assessed between CSM and control horses. The same categories of anatomic

location of the lesion within the articular process as well as location in the cervical
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column with respect to compression were analyzed. Significance was observed in

all comparisons except for superficial lesions at noncompression sites. Distribution
of lesion grade for all comparisons is shown below (Figure 3.4).

Figure 3.4: Articular process lesion severity distribution. Data are presented as the
percent of the total number of lesions for each grading category. Severity
distribution patterns were significantly shifted to greater severity in CSM horses in
all categories except for superficial lesions at noncompression sites. Blue bars
represent the control group and red bars represent the CSM group. * p value < 0.05;
** p value < 0.01
Microarchitectural Bone Volume Assessment
A subset of lesions identified on MRI was imaged using micro-CT for

assessment of trabecular bone volume and an evaluation of trabecular bone

architecture. No significant differences in trabecular bone volume were found

(p>0.05) when comparing the articular processes with superficial lesions to controls,
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articular processes with deep lesions to controls, or combination of the two groups
(Table 3.2).

Lesion Categorization
Deep Lesion
Trabecular Bone Volume
Superficial Lesion
Trabecular Bone Volume
All Articular Processes
Trabecular Bone Volume

Sample Groups
CSM (n=4)
0.3885 ±0.04
CSM (n=4)
0.3591±0.02
CSM (n=8)
0.3738±0.03

Control (n=4)
0.3431±0.02
Control (n=4)
0.3495±0.03
Control (n=8)
0.3463±0.02

p-value
0.087
0.500
0.059

Table 3.2: Trabecular bone volume comparisons in articular processes. Data are
represented as the percentage of total volume occupied by trabecular bone based on
micro-CT analyses. Averages and standard deviations for each group are listed. No
significant differences between control and CSM horses were identified.
Analyses of deep lesions on micro-CT demonstrated that they were not

composed of bone (Figure 3.5). This finding was observed in all 4 articular

processes analyzed in the deep lesion group. An absence of bone was also observed
for superficial lesions in the four articular processes examined, including when
there was extension of the lesion into the subchondral region (Figure 3.6). In

contrast, perilesional regions often, but not always, exhibited trabecular thickening
consistent with areas of bone sclerosis (Figures 3.5 and 3.6).
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Figure 3.5: Micro-CT and MRI of a deep lesion within the articular process. This is
the left cranial articular process from C7 of a CSM horse. The left image is a 3D
model generated by micro-CT showing a deep lesion in cross section. A discrete
focus with absence of trabecular bone structure is observed (green arrow). On the
right, the MR image is localized to the same level as the 3D model. A focal signal
increase within the trabecular bone is seen (yellow arrow). The difference in
resolution between the imaging modalities accounts for the size discrepancy of the
lesion in each of these images.

Figure 3.6: Micro-CT and MRI of a superficial lesion within the articular process.
This is the left cranial articular process from C4 of a CSM horse with a grade 2 lesion
identified on MRI. The left image is a 3D model of the articular process in cross
section. At the green arrow is an invagination into the subchondral bone that is not
composed of bone. Adjacent to the invagination, the trabecular bone is markedly
thickened (sclerosis). On the right is the corresponding localization of the lesion on
MRI. There is a focal signal increase that extends from the articular surface into the
subchondral bone (yellow arrow). Also, there is an adjacent decrease in signal
indicating bone sclerosis consistent with the thickened trabecular bone observed on
micro-CT.
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Histopathologic Assessments
All superficial lesions identified in CSM and control horses were consistent

with varying degrees of osteochondrosis. Both osteochondrosis manifesta (OM) and
osteochondritis dissecans (OCD) were observed (Figure 3.7 and 3.8). Since the

lesion grading categories were based on size, both OM and OCD were seen in grade

2 and grade 3 categories. Associated with the cartilaginous defects was a moderate
to severe thickening and remodeling of the subchondral bone, which extended
variably into the trabecular bone of the articular process.

Figure 3.7: Osteochondrosis manifesta lesion (grade 3) image series. On the left is a
gross image of the articular defect (arrow) identified on left caudal C6 of a CSM
horse. The middle image is the same lesion on MRI. The arrow indicates an
irregular chondro-osseous margin with an adjacent increase in signal intensity. On
the right, is a photomicrograph of the same lesion at 2X magnification. There is a
focal area of cartilage necrosis (arrows) surrounded by thickened subchondral bone.
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Figure 3.8: Osteochondritis dissecans lesion (grade 3) image series. On the left is a
gross image of the articular defect (arrow) identified on the left caudal articular
process from C2 of a CSM horse. The middle image is the same lesion on MRI
(arrow) composed of a slightly irregular chondro-osseous margin with an increase
in signal intensity extending into the bone. On the right is a photomicrograph at 2X
magnification. The arrow indicated the separation of the articular cartilage from the
bone consistent with OCD.
Deep only lesions in CSM horses were composed of cyst-like structures

within the trabecular bone, fibrous tissue replacement of trabecular bone, and

retention of variably size foci of cartilaginous matrix deep in the trabeculae (Figure

3.9). Cells lining the lumen of the cyst-like structures were negative for cytokeratin,

a marker for epithelium. Cyst-like structures were surrounded by organized fibrous
connective tissue. The two deep lesions identified in control horses were both
retention of small to moderate amounts of cartilaginous matrix within the

trabecular bone. No cyst-like lesions in the articular processes of control horses
were observed.
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Figure 3.9: Image series of cyst-like structures in deep articular process lesions of
CSM horses. Image A shows a cyst-like structure in the trabecular bone at 2X
magnification. Higher magnification (10X) of the same structure is seen in figure B.
The cyst-like structure is composed of a surrounding fibrous stroma with no
discernable epithelial lining. Image C shows a different cyst-like structure (green
arrow) at 4X magnification surrounded by trabecular bone sclerosis (asterisk). The
cells lining the cyst-like structure are shown at 40X magnification in figure D (green
arrow).
Mixed lesions were composed of a variety of pathologies. Consistent with the

superficial only lesions, the superficial component of the mixed lesions fell under

the spectrum of osteochondrosis. The deep lesions away from the articular surface

were composed of areas of fibrous replacement of trabecular bone with active bone
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remodeling, cyst-like structures, occupation of the marrow cavity with varying

amounts of fibrous connective tissue, and mature venous sinuses within the marrow
space (Figure 3.10).

*

A

B

D

C

Figure 3.10: Histopathology photomicrographs of the deep lesions in the mixed
category. Figure A shows normal trabecular bone (yellow arrow) and marrow space
(green arrow) at 2X magnification. Replacement of trabecular bone with dense
streams and bundles of fibrous connective tissue (*) is shown in figure B at 10X
magnification. On the bottom left in figure C, organized prominent venous sinuses
occupy the marrow space with paucity of normal marrow elements at 20X
magnification. Loosely organized fibrous connective tissue replacing hematopoietic
elements in the marrow space is shown in figure D at 10X magnification.
Discussion
The objective of these experiments was to evaluate and compare the

frequency and severity of skeletal lesions in articular processes of cervical vertebrae
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identified on MRI between CSM and control horses. A representative subset of these
lesions was further characterized using micro-CT and routine histopathology.

Lesion frequency, location, and severity analyses examined the cervical column as a
whole, at the site of cord compression, and away from the site of compression.
While lesions were observed in both control and CSM horses, frequency and

severity were significantly increased in the CSM group. Lesion frequency was

higher in the CSM horses across the entire cervical column for both superficial and
deep lesions, as well as for deep lesions at noncompression sites. In addition,

identified lesions had an increased severity in the CSM horses. These data support
previous work that concluded pathology in the neck of CSM horses is generalized
and not limited to the site of compression (Stewart et al., 1991).

A variety of lesions were observed on histopathology of the articular

processes. All superficial lesions identified on MRI that were further evaluated

using histopathology fell under the continuum of osteochondrosis (OC). OC is a
developmental disease that results from localized failure of endochondral

ossification. Recently, efforts to improve nomenclature for OC has resulted in 3

categorizations, osteochondrosis latens, osteochondrosis manifesta, and

osteochondritis dissecans (Ytrehus et al., 2007). Osteochondrosis latens is a focal
area of cartilage necrosis within the epiphyseal cartilage. When cartilage necrosis
extends into the adjacent subchondral bone it is classified as osteochondrosis

manifesta. The most severe manifestation, osteochondritis dissecans, occurs when
the integrity between the cartilage and bone is lost and a flap or loose body of

cartilage is released. Osteochondrosis manifesta lesions were observed in control
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and CSM horses whereas OCD was only seen in CSM horses. The presence of OCD in
CSM horses is supportive of the increased severity distribution in CSM pathology.
On micro-CT, the four OC lesions evaluated had loss of bone structure consistent

with the retention of cartilage through failure of endochondral ossification.

Osteochondrosis in the cervical column of CSM horses has been reported previously

(Stewart et al., 1991; Mayhew, 1978). Findings in this study further substantiate the
association of OC with CSM.

Deep lesions on MRI displayed a variety of histopathological changes. An

interesting finding was the presence cyst-like structures within the trabecular bone
away from the articular surface in the CSM horses. This is the first report of these
lesions in the articular processes of CSM horses. On micro-CT, all 4 articular

processes with deep lesions were visualized as focal areas with an absence of

trabecular bone structure (Figure 3.5). Histopathology confirmed that 3 of the 4
deep lesions analyzed using micro-CT were cyst-like structures composed of an

empty lumen surrounded by organized fibrous connective tissue. Classically, bone
cysts are characterized as simple, subchondral, or aneurysmal (Carlson and

Weisbrode, 2012). Simple cysts are lined by fibrous tissue and contain clear to

serosangiunous fluid. Remodeling of the bone adjacent to the cyst can be a feature
as well. Cyst-like structures observed in the articular processes fit best with the

simple categorization. The exact cause of simple bone cysts is unknown. Suspected

causes include vascular malformations, hemorrhage, ischemic necrosis, occlusion of
venous drainage, or developmental abnormalities (Carlson and Weisbrode, 2012;
Chigira et al., 1983; Khurana JS, 2009).
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The identification of these cyst-like structures generates the following

question: are these structures related to osteochondrosis in some fashion? As
noted earlier, OC is a developmental problem of endochondral ossification

impacting bone and cartilage in diarthrodial joints. Subchondral bone cysts

adjacent to the articular cartilage have been described with OC. It is unknown at

this time if the cyst-like structures in the current study were another manifestation

of OC or independent. Their localization was frequently deep in the trabecular bone
away from the articular cartilage-subchondral bone interface, which could be a
confounder for a direct relationship with OC.

While the identification of the cyst-like structures is novel in the articular

processes, there are previous reports of this pathology in other bones of the horse.
Osseous cyst-like lesions have been reported in the appendicular joints of horses,

specifically the fetlock joint, carpal joint, tarsus joint, navicular bone, and phalanges

(Murray et al., 2011; Anastasiou et al., 2003). The presence of these lesions is often
associated with trauma, but can also be related to developmental factors. Clinical
significance of these lesions in the appendicular joints can be either incidental or
pathologic. If the surrounding bone is normal, then cyst-like lesions are usually

interpreted as incidental. In cases where adjacent sclerosis is observed, cyst-like

lesions are considered pathologic (Powell, 2011; Murray et al., 2011). Using these
criteria, both incidental and pathologic cyst-like structures were observed in the
CSM horses.
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Several other interesting lesions were observed in individual cases. In

articular processes from a 6 month old colt with CSM, well-defined, prominent

venous sinuses were observed scattered in the marrow space both adjacent to the
articular surface near OC lesions and deep in the trabecular bone (Figure 3.10).

Hematopoietic elements in these areas were rare. Given the fluid nature of blood,
the lesions were visualized as multifocal pinpoint increases in signal intensity on
MRI. Their significance is unclear.

Another interesting lesion observed in several cases was varying degrees of

fibrous replacement of marrow elements and trabecular bone often surrounded by

marked bone remodeling (Figure 3.10). This fibrosis was observed near OC lesions
and in the trabecular bone without communication to the articular surface. The

remodeling bone was characterized by haphazardly arranged trabeculae lined by

osteoblasts (woven bone), and scalloped basophilic cement lines indicative of active
bone resorption and replacement. These foci of fibrous connective tissue and

collagen surrounded by bone remodeling could represent sites of previous injury

that are in the process of stabilization and repair. Foci closer to the articular surface
could be a response to adjacent chronic OC lesions. The cause of the fibrous foci
deeper in the trabecular bone is unknown, but interesting nonetheless. One

possibility is the deeper lesions could be previous cyst-like structures that collapsed

and are now in a healing process. Identification of the original cause of these fibrous
lesions may help clarify contributing steps in the pathogenesis of CSM.

66

Previous studies have described trabecular bone sclerosis in the dorsal

lamina and vertebral body endplates of vertebrae in CSM horses (Mayhew, 1978;

Powers et al., 1986; Trostle et al., 1993). Bone sclerosis can develop due to impaired
function of osteoclasts and osteoblasts, as well as metabolic signals that affect

normal remodeling and resorption. However, osteosclerosis can also occur as a

compensatory response to increased mechanical stress with suppression of bone

resorption resulting in an increase of bone mass as described in Wolff’s law. When
occurring in response to biomechanical forces, areas of osteosclerosis contain

normal sized lacunae (Powers et al., 1986; Trotter et al., 1976; Wright et al., 1973;
Parfitt, 1977). This was observed for the sclerotic regions of subchondral and

trabecular bone in the current study, implicating biomechanical forces as the cause
versus an impairment of normal bone turnover from cellular or hormonal
mechanisms.

Given previous reports and the observations in the current study of

osteosclerosis in the articular processes, the trabecular bone volume of the entire
articular process in CSM and control horses was evaluated. Although mean

trabecular bone volumes were numerically greater in CSM horses in each category
(Table 3.2), the differences were not significant. Combining samples from the

superficial and deep lesion groups yielded a p value of 0.051. Given the extent of
trabecular bone thickening perceived in the superficial, deep, and mixed lesions

during histopathologic examination, it is possible that with an increase in sample

size, significant trabecular bone volume differences would be detected. Analyses of
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bone volume in lesion areas relative to areas distant from any lesions identified on
MRI would also be interesting.

Other comparisons that were not significant included the frequency of

superficial lesions regardless of site, frequency of superficial lesions at

noncompression sites, and the severity of superficial lesions at noncompression
sites. A possible explanation is that all superficial lesions in this study were

identified as some form of osteochondrosis. Prevalence of osteochondrosis in the

Thoroughbred is estimated at ~25% (Lepeule et al. 2009) and has been documented
in the cervical column of horses previously (Stewart et al., 1991 and Mayhew, 1978).
The prevalence of osteochondrosis in general and its observation in both control

and CSM horses in this study may explain the lack of significance in several of the
superficial lesion comparisons.

MRI studies permit cervical column evaluation in situ allowing for a more

complete identification and assessment of articular process pathology associated
with CSM. Consistent with a previous report, pathology was not localized to only

compression sites, but observed throughout the cervical column (Stewart et al,
1991). These findings support a generalized issue of bone and cartilage in the

cervical column. The focus of this study was pathology of the articular processes. It
would be useful to investigate if similar bone and cartilage lesions are observed in
other parts of the vertebrae, as well as in the appendicular skeleton.

The new data reported provide further evidence that developmental

aberrations of cervical vertebrae morphogenesis is important in the pathogenesis of
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equine CSM, manifested as both osteochondrosis and cyst-like-lesions. In contrast,

osteosclerosis may reflect a compensatory response in still maturing CSM horses to
abnormal biomechanical stresses on the cervical column. Therefore, both

developmental and biomechanical mechanisms may lead to the bone and cartilage

changes observed in CSM. A model where biomechanical changes are secondary to
primary developmental issues seems more likely. The intersection of

developmental and biomechanical influences in the growing horse sets the stage for
a complex interaction of variables. Future studies focusing on associations of CSM

etiologic factors (high planes of nutrition, abnormal growth rates, abnormal copper

and zinc levels, inherited genetic determinants) with specific bone and cartilage
pathology in cervical vertebrae will help further elucidate the pathogenesis of
equine CSM.

Copyright © Jennifer Gail Janes 2014
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Chapter 4
The Role Of Inherited Genetic Determinants In Equine Cervical Stenotic
Myelopathy
Summary
Experiments in this chapter tested the hypothesis that inherited genetic

determinants contribute to the susceptibility of equine cervical stenotic myelopathy
(CSM). Single nucleotide polymorphism (SNP) allele frequencies in the genomic
DNA (gDNA) of carefully phenotyped CSM horses (n=59) were compared to

population data (n=427) using the Equine SNP50 and Equine SNP70 Bead Chips for
a genome wide association study (GWAS). Results of the GWAS identified multiple
significant loci, both individual SNPs and haplotypes, across the genome. An

additional association analysis was conducted by comparing the inheritance of

genomic copy number variants (CNVs) across 8 individuals in a single family with a
high incidence of the disease. The data support a genetic contribution to the

etiology and/or pathogenesis of CSM, with inheritance likely complex in nature

involving multiple gene loci. Results are consistent with the understanding that
CSM is influenced by both genetic and environmental variables.
Introduction

Cervical stenotic myelopathy (CSM) results from malformations in the

cervical vertebrae, which leads to vertebral canal stenosis and spinal cord
compression. The condition is thought to be multifactorial, with both

environmental and genetic variables contributing to etiology and pathogenesis.
Known environmental factors include accelerated growth rates, high planes of

nutrition, and altered copper and zinc concentrations. The importance of heritable
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genetic determinants in regards to equine CSM has been studied by several groups,
but remains an unresolved and debated issue.

An initial published investigation for the role of genetic determinants came

from a multigenerational pedigree analysis looking at 6 Thoroughbred families

(Dimock, 1950). Sire lines were examined and concluded that 43% of CSM progeny
in the pedigrees traced to one of the three Thoroughbred foundation sire lines. A

possible recessive inheritance, but not simple autosomal recessive was suggested
from this work. Additional support for a possible recessive mode of inheritance
came from a German investigator (Weischer, 1944; Weischer, 1946), based on

observations. Previous to this, it was suggested that particular mares produced

multiple affected offspring (Errington, 1938). Finally, there are numerous anecdotal
reports predominately within Thoroughbred horses, but other breeds as well, of

particular sires or dams that seem to produce an increased number of CSM progeny.

There are also published papers to the contrary, where investigators reached

a conclusion that genetic determinants have a limited role in the development of

CSM. Pedigrees of British Thoroughbreds with CSM were examined in comparison
to controls (Falco et al., 1976). It was noted there was no increase in disease

incidence in closed inbreeding populations, arguing against a simple recessive mode
of inheritance. Additional smaller studies found no support for inheritance as well
(Steel et al., 1959; Jones et al., 1954; Schultz et al., 1965). Wagner and colleagues

(Wagner et al., 1985) conducted a prospective breeding study crossing dams and

sires each with a confirmed diagnosis of CSM. Progeny were closely monitored with
71

serial neurologic examinations and radiographs for the onset of neurological deficits
up to one year of age. None of the foals developed CSM during this study period.

However, an increased incidence of other developmental orthopaedic diseases were
noted such as physitis, contracted tendons, and osteochondrosis. This study

effectively ruled out a simple mode of inheritance for CSM, but it is still possible CSM
might be one clinical manifestation of a complex hereditary disease.

The current study was designed to test the hypothesis that inherited genetic

determinants contribute to the susceptibility or pathogenesis of CSM. Identification
of possible associations between single nucleotide polymorphisms (SNPs),

haplotypes, and copy number variants (CNVs) with the CSM phenotype was carried
out using both population- and family-based approaches.
Materials and Methods
Experimental Samples
SNP Association Sample Selection:

A total of 59 Thoroughbred horses with CSM were identified for study. Study

subjects were limited to Thoroughbreds to eliminate breed as a variable and reduce
confounding genetic heterogeneity unrelated to CSM. Two different phenotyping
levels were used for identification of CSM cases (Figure 4.1). Fully phenotyped

horses underwent antemortem and postmortem examinations as was previously

outlined in chapter 2 of this thesis. A second classification level of CSM cases was a
clinical diagnosis cohort. These horses were identified based on neurologic

examination and standing cervical radiographs that strongly supported a clinical
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diagnosis of CSM. Also, a subset of horses in this group had a myelogram and/or
surgical intervention. For all CSM study subjects, clinical diagnosis needed to be
made by 5 years of age. The control group was composed of 6 fully phenotyped
horses that had no clinical neurological deficits and no evidence of spinal cord
pathology on postmortem, as well as archived SNP data from 427 general
population Thoroughbreds genotyped for reasons unrelated to CSM.
Fully Phenotyped:
Clinical Diagnosis:
Breed Examined:
Age Parameter:
Gender of Cases:

Clinical neurologic examination, standing cervical
radiographs, postmortem confirmation of cervical spinal
cord compression
Clinical neurologic examination, standing cervical
radiographs, myelogram and surgery in subset of cases
Thoroughbred only
Clinical CSM diagnosis made at 5 years of age or younger
53 males; 6 females

Figure 4.1: Summary of the phenotypic assessment and signalment parameters for
CSM horses in the study.
CNV Association Sample Selection

A Thoroughbred family with an increased incidence of CSM was identified for

CNV analysis (Figure 4.2). This family was also included in the SNP analysis. All
CSM horses within the family were phenotyped at the clinical diagnosis level.

Absence of the CSM phenotype in the other progeny labeled as ‘control’ was inferred
based on productive athletic careers in racing and personal correspondence. Two

progeny, one CSM and one control have the same sire. This sire was also analyzed.
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Figure 4.2: Pedigree of family included in CNV and SNP analysis. The solid blue fill
indicates the horse was included for analysis. The phenotype status for known
progeny is listed as CSM or control. Open shapes with no CSM or control
categorization indicate the specific phenotype for that horse is unknown. * indicates
the same sire for both progeny. This sire is included for analysis as well.
DNA Isolation
Whole blood samples were collected in ethylenediaminetetraacetic acid

(EDTA) tubes from CSM horses, the 6 fully phenotyped controls, and the family

samples. Genomic DNA (gDNA) was extracted using the Gentra Puregene Blood kit
and protocol from Qiagen (Germantown, MD). Spectrophotmetric analysis

(Maniatis, 2012) was used to quantify gDNA and assess purity. Samples were
diluted to 100ng/μl ± 10ng/μl for genotyping submission.
Genotyping

SNP Genotyping Arrays

For SNP genotyping, both the Equine SNP50K Bead Chip (Illumina),

composed of 54,602 SNPs, and the Equine SNP70K Bead Chip (Illumina), which

contains 65,157 SNPs, platforms were used. Polymorphisms are distributed across
the autosomes and X and Y chromosomes, but these chips contain only two Y

chromosome SNPs. Between the two platforms 45,703 markers are shared.

Samples were sent to Geneseek (Omaha, NE) for genotyping. A summary of the
phenotype classification and array used is given below (Figure 4.3).
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Figure 4.3: Summary of the samples genotyped on each array. The number of
samples and phenotype classification is provided.
CNV Array

Genomic DNA samples from the family samples (Figure 4.2) were run on a

custom designed exome tiling array (Doan et al., 2012). The array consists of
418,576 unique oligonucleotides distributed across all autosomes and the X

chromosome (Agilent Technologies Inc.). Oligonucleotides range from 45-60bp in
length. Preparation of gDNA samples for comparative genomic hybridization was
performed according to a published protocol (Doan et al., 2012). Arrays were
scanned on an Agilent High Resolution Microarray Scanner 62505C (Agilent

Technologies Inc.). Feature extraction 10.5 software (Agilent Technologies, Inc.)
was used to extract data.

Quality Control for Data Analysis
SNP Array Quality Control

Genotype data from both 50K and 70K arrays were merged for data analysis.

Quality control and association analyses were performed using the SNP Variation
Suite (SVS) version 7 software (Golden Helix Inc.). SNPs were excluded based on
genotyping rate < 0.90, minor allele frequency <0.01, and Hardy Weinberg
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equilibrium p value < 0.001 thresholds. After these filters, 33,729 SNPs were left for
analysis. Samples were also checked for gender discrepancy. Nine samples from
the general population data were excluded for indeterminate gender assignment
based on data provided.

Identification of Cryptic Relatedness and Population Structure

For identification of cryptic relatedness, a genomic best linear unbiased

predictor (gBLUP) relationship matrix was constructed (vanRaden, 2008). The
kinship matrix was based on genotypes and corrected for gender. This matrix

functions to control for relatedness between samples that can lead to spurious
associations. Population structure, another variable that can lead to spurious

association, was addressed using principal component analysis (PCA). The first

principal component was determined to be the best correction for structure and

was used as a covariate in the association study (Figure 4.4). Inclusion of the first

principal component in the mixed model produced the lowest Bayesian Information
Criterion (BIC) value (Segura et al., 2012).
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Figure 4.4: Scatter plot of 1st and 2nd principal components. The overlay of case and
control samples supports minimal population structure in the data set. Control
horses are blue diamonds. CSM horses are green diamonds.
CNV Array Quality Control

All arrays passed quality control checks using the feature extraction software

for uniform signals in spots, background noise, and signal intensity achieving “good”
or “excellent” assessments.

Statistical Analysis
Mixed Model Analysis for SNP GWAS

A mixed model analysis approach for additive effects was used for the SNP

genome wide association analysis. This approach allows for the incorporation of

fixed and random effects while correcting for relatedness. The multi-locus mixed
model (MLMM) option was selected in SVS given the likelihood of CSM being

controlled by a complex of multiple variants (Segura et al., 2012). The kinship

matrix was included in the model along with the first principal component and
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gender as covariates. A p value of < 0.05 after the Bonferroni correction was
determined to be significant.
Haplotype Analysis

A case control association analysis was also performed evaluating haplotypes.

This analysis was performed in SVS using precomputed haplotype blocks. The

precomputed block method defines haplotype block boundaries using a confidence

interval algorithm for identifying linkage disequilibrium (Gabriel et al., 2002). This
method identified 4,790 variably sized blocks. A second method defined haplotype
blocks based on a sliding window of 5 markers moving along all SNPs regardless of
the degree of linkage disequilibrium. It defined 33,697 haplotype blocks. The Chi
squared statistic with both the Bonferroni correction and 10,000 full scan

permutations for multiple testing correction were computed. A p value of < 0.05
after either the Bonferroni correction or 10,000 maximum permutations was

identified as significant. The Bonferroni correction is calculated by dividing the

number of samples by the total number of tests. In this case, each SNP represents an
individual test. Haplotype frequencies were computed using EM estimation
(Dempster et al., 1977; Excoffier and Slaton, 1995).
Copy Number Variant Identification

Copy number variants from the dam in the family pedigree (Figure 4.2) were

called in Agilent Genomics Workbench 5. The aberration detection method 2 (ADM-

2) algorithm identified CNVs in respect to a reference sample. The reference sample

was a male Thoroughbred defined as a control based on absence of neurologic signs

and lesions consistent with CSM on clinical and postmortem examination. The list of
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CNVs detected in the dam was compared to the equine (various breeds) CNV

database at Texas A&M for identification of aberrations unique to the mare. These

dam-specific CNVs were then analyzed for segregation to her progeny and level of
association with the CSM phenotype.
Results

Correction for Relatedness and Population Structure:
In order to account for possible spurious associations due to cryptic

relatedness among samples or possible population structure, gBLUP and PCA were

used respectively. Q-Q plots were constructed to evaluate the effectiveness of these

two methods (Figure 4.5). In the plot on the left there is a gradual deviation of SNPs
from the line indicating genomic inflation that could lead to false positives. The plot
on the right is the data after correction, where SNPs follow the line until the distinct
upward deviation at the lowest P values. These methods appeared to have
sufficiently corrected for relatedness and structure in the data set.

Figure 4.5: Q-Q plots before and after methods for structure correction. Each blue
box represents an individual SNP. The plot on the left is the data without correction
and a gradual deviation from the line is observed consistent with inflation. The plot
on the right is after the use of gBLUP and PCA and the inflation has resolved.
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Chestnut Coat Color Association
Coat color information based on individual registration records from the

Thoroughbred breed organization was acquired for each horse. This information

was used to run a chestnut coat color association analysis as a positive control for
the data set. The association identified a significant association on ECA 3 in the
region of the MC1R gene, which is known to control the chestnut coat color
phenotype (Figure 4.6).

Figure 4.6: Manhattan plot for chestnut coat color association analysis. Each
colored box represents an individual SNP. The negative log of the p value is
displayed on the y-axis scale. Position along the x-axis indicate the individual
equine chromosomes. The red line defines significance based on the Bonferroni
correction for multiple testing. A strong peak of SNPs in linkage disequilibrium is
observed on ECA 3 in the region of the MC1R gene known to control for the chestnut
coat color phenotype.
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SNP-based Association Analysis
Results of the SNP mixed model analysis with additive effects identified two

SNPs with association to the CSM disease phenotype. Significance was assigned

based on p < 0.05 after the Bonferroni correction. SNPs are located on ECA 12 and
ECA X (Figure 4.7).

Figure 4.7: Manhattan plot for mixed model analysis with additive effects. The red
line indicates significance based on the Bonferroni correction for multiple testing.
SNPs on ECA 12 and ECA X are positioned above the significance threshold.
The allele frequencies and distribution of genotypes of the significant SNPs

identified in the mixed model analysis between the case and control groups are
summarized in the table below.
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SNP ID
BIEC2_193603*

Location (Chr.bp)
12.22368861

P value
4.17e-10

BIEC2_1109022

X.8192913

7.07 e-7

Genotype
AA
AG
GG
AA
AC
CC

Cases n=59
32 (54.2%)
24 (40.7%)
3 (5.1%)
40 (68.0%)
4 (6.7%)
15 (25.4%)

Controls n=424
340 (80.2%)
72 (17.0%)
3 (0.71%)
351 (83.0%)
50 (11.9%)
23 (5.0%)

Table 4.1: Summary of the location and genotypes of significant SNPs in the mixed
model analysis. *Control group had 9 samples for which the genotypes of
BIEC2_193603 were not called. Chr = chromosome; bp = base pair.
Haplotype Analysis
Significant haplotypes were identified using both the precomputed block and

sliding window of 5 makers. In one or both approaches, significant haplotypes were
identified that included the two individual significant SNPs on ECA 12 and ECA X.

The location of significant haplotypes using both methods is depicted below (Figure
4.8 and 4.9). Estimated haplotype frequencies were also calculated (Table 4.2 and
4.3). Significant haplotypes varied between 5.9%-28.81% in the CSM group;

whereas the haplotype frequency in the control group was below 11.1%. The
degree of linkage disequilibrium (LD) varied in the regions covered by the
significant haplotypes.
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Figure 4.8: Manhattan plot of haplotypes using blocks defined by the precomputed
block method. The red line indicates significance after applying the Bonferroni
correction. The y-axis is the Chi squared statistic. Each individual box presents the
first SNP in each haplotype. Significant haplotypes are located on ECA 10 and ECA X.

Chr

Basepair

Haplotype

ECA X*
ECA 10

7,959,875-8,192,913
80,425,724-80,478,372

AGAAC
GAGA

Overall
Freq
13.23%
13.71%

CSM
Freq
28.80%
6.14%

Control
Freq
11.07%
0.72%

Bonf p
value
0.001
0.038

Perm. p
value
0.055
0.235

Table 4.2: Summary of the significant estimated haplotypes identified by the
precomputed block of markers. *Indicates haplotype contains significant SNP from
individual SNP analysis. Freq.= frequency; Bonf.= Bonferroni; Perm.= permutation
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Figure 4.9: Manhattan plot of haplotypes using blocks defined by a sliding window
of 5 markers. The yellow line indicates significance of p < 0.05 after applying the
10,000 maximum permutations of the data. The red line indicates significance after
applying the Bonferroni correction. The y-axis is the Chi squared statistic. Each
individual box presents the first SNP in each haplotype. Significant haplotypes are
located on ECA 2,6,12,16,27, X.

Chr

Basepair

Haplotype

ECA 2
ECA X
ECA X*
ECA X
ECA X
ECA X
ECA 6
ECA 27
ECA 16
ECA 16
ECA 12*

98,861,186-98,960,646
5,790,320-5,983,253
7,963,553-8,196,534
9,204,707-9,322,958
11,478,740-11,558,592
80,036,076-81,737,962
37,546,839-38,002,001
30,165,151-30,499,043
17,568,806-17,754,789
52,363,165-52,401,989
22,162,774-22,688,422

AGCGG
AAAAG
GAACA
CAGGA
AGAGC
AAAAA
GGGAA
GCCAG
GAAGG
GGACG
AGGGG

Overall
Freq
2.51%
1.46%
13.3%
3.20%
2.36%
3.83%
1.57%
1.04%
1.22%
3.80%
1.50%

CSM
Freq
12.39%
6.90%
28.81%
13.12%
11.02%
15.79%
8.65%
5.91%
6.32%
12.65%
6.63%

Control
Freq
1.13%
0.71%
11.10%
1.81%
1.06%
2.13%
0.64%
0.36%
0.51%
2.60%
0.74%

Bonf p
value
4.46e-8
0.029
0.016
1.34e-5
1.48e-6
2.73e-7
9.91e-5
0.004
0.042
0.006
0.043

Perm. p
value
0.002
0.360
0.299
0.023
0.008
0.004
0.044
0.170
0.418
0.212
0.421

Table 4.3: Summary of the significant estimated haplotypes identified by the sliding
window of 5 markers. *Indicates haplotype contains significant SNP from individual
SNP analysis. Freq.= frequency; Bonf.= Bonferroni; Perm.= permutation
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One megabase windows on either side of significant regions were used to

curate lists of protein coding genes, pseudogenes, and other elements (Table 4.4).
Ensembl.org was used to identify these elements.
Chr
ECA 2
ECA X
ECA X*
ECA X
ECA X
ECA X
ECA 6
ECA 27
ECA 16
ECA 16
ECA 12*
ECA 10

Basepair
98,861,186-98,960,646
5,790,320-5,983,253
7,963,553-8,196,534
9,204,707-9,322,958
11,478,740-11,558,592
80,036,076-81,737,962
37,546,839-38,002,001
30,165,151-30,499,043
17,568,806-17,754,789
52,363,165-52,401,989
22,162,774-22,688,422
80,425-724-80,478,372

Gene Summary
Protein Coding
2
10
9
16
22
59
35
2
9
12
73
12

Pseudogenes
4
7
0
1
8
17
9
1
3
9
22
3

Types of RNA
2
0
2
3
1
3
0
2
0
3
12
0

Table 4.4: Summary of protein coding genes, pseudogenes, and RNA elements in
significant loci. The window used for identifying these elements extends 1 MB on
either side of the stopping points of the basepair column. * indicates this region
contains a significant SNP from the individual SNP analysis.
CNV Identification
A total of 276 CNVs were called in gDNA from the dam of the previously

described family pedigree (Figure 4.2). When compared to the equine CNV database,
this mare had 207 unique aberrations (Figure 4.10). Unique is defined as CNVs

identified in the mare only and not present in the database. Sixty-nine CNVs were

identical between the mare and common CNVs in the database. Finally, 4,987 CNVs
in the database were not identified in the mare. Three CNVs were found to

segregate with the CSM disease phenotype (Table 4.5). Of these 3, an amplification
on ECA 9 has not been described previously as a locus for CNV polymorphism.
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Whereas the other two, both of which suggest heterozygous deletions on ECA 7,
were located at loci already listed in the equine CNV database.

207

69

4,987

Figure 4.10: Venn diagram of unique common CNVs between the dam and the
database. The yellow circle represented CNVs called in the dam. The blue circle
represents CNVs from the database.
Chromosome
ECA 7
ECA 7
ECA 9

Start base pair
34,644,877
52,736,448
31,306,365

Stop base pair
34,682,871
52,736,967
31,306,958

Direction
Deletion
Deletion
Amplification

Table 4.5: Summary of CNVs in the dam that segregates only with CSM progeny.
Two deletions on ECA 7 and one amplification on ECA 9 were identified in all CSM
horses in this family.
Discussion

The focus of these experiments was to re-examine the long-standing question

regarding the role of genetic determinants in the etiology and/or pathogenesis of
CSM using genome-wide assessments of polymorphic DNA markers. This was
accomplished by performing GWAS analyses to evaluate SNP and haplotype

associations between horses with CSM and the general Thoroughbred population.
Results of this analysis identified multiple significant loci associations distributed

across the genome supporting a genetic contribution in some fashion to the etiology
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and/or pathogenesis of CSM. Significant SNPs identified on ECA 12 and X were also
included in significant haplotypes. In addition, significant loci were identified on
ECA 2, 6, 10, 16, and 27.

An important consideration is what can be determined from the data in

regards to the possible inheritance pattern. The GWAS for the CSM disease

phenotype, assessing both individual SNPs and haplotypes, identified significant loci
across multiple chromosomes. This finding is not consistent with a simple mode of
inheritance, but instead, suggests a more complex genetic trait. These data are

supportive of earlier pedigree and breeding studies (Dimock, 1950; Errington, 1938;
Weischer, 1944; Wagner et al., 1987) that also concluded a simple mode of

inheritance was unlikely. The multiple associations with CSM is in contrast to the
single strong focal peak observed for chestnut coat color, composed of numerous
SNPs on ECA 3 in the region of the MC1R gene known to regulate the chestnut
phenotype with a recessive mode of inheritance (Marklund et al., 1996).

For complex traits, often there are multiple genomic loci and variants

involved that individually have a small effect, but in combination can reach a

threshold affecting the phenotype (McCarthy et al., 2008). Complex diseases in the
human literature include Crohn’s disease and type 2 diabetes (Bao et al., 2013;

Tsianos et al., 2012), where multiple genetic loci in combination with environmental
factors lead to manifestation of clinical disease. CSM is most likely a similar

situation. Established environmental factors that contribute to CSM include high

planes of nutrition and increased growth rates. The model predicts environmental
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factors and inherited genetic variants interacting in potentially complex ways to
produce the CSM disease phenotype.

SNPs and haplotypes significantly increased in CSM over controls are

candidate susceptibility or risk loci. Conversely, polymorphic markers found to be
significantly increased in control horses may be close to genes that influence

protective mechanism. Regions on ECA 12 and ECA X are particularly interesting

given they were significant on the analysis of both individual SNPs and haplotypes.
One megabase genomic intervals on either side of significant SNPs and haplotypes

were examined for possible genes of interest (Table 4.4). Genes identified in these
regions were associated with a variety of ontologies. One specific gene of interest,

neuronal membrane glycoprotein gene (GPM6B) located on ECA X, has been shown
to regulate osteoblast function and bone formation (Drabek et al., 2011). GPM6B
controls cytoskeleton formation and matrix vesicle release for mineralization.
Osteosclerosis, increased bone density due to the presence of excessive

mineralization, is a pathologic lesion associated with CSM (Mayhew, 1978; Powers
et al., 1986; Chapter 3). Therefore, GPM6B could be a gene of interest for future
studies.

Identification of regions of interest on the X chromosome is potentially

interesting given the prominent gender bias of male over females in this disease.

Since males are hemizygous for the X chromosome, they will express an X-linked

disease whether it is dominant or recessive. It is unlikely that CSM is completely
explained by an X linked inheritance, but the potential contribution of the X
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chromosome and the documented male over female bias is interesting. A role for

the X chromosome is also intriguing given anecdotal evidence of “unaffected” dams
producing CSM offspring.

The CNV experiment looked for association of specific copy number variants

with the CSM disease phenotype. The family studied is unusual given the increased

number of affected horses, since the overall prevalence of CSM in the Thoroughbred
population is estimated at 2% (Oswald et al., 2002). It is possible this mare could

have additional or even unique de novo mutations contributing to the high incidence
of disease observed. In a preliminary analysis of the CNV data, the index mare

contains 207 unique CNVs relative to an equine CNV database (Figure 4.10). This

database is comprised of data from a multiple horse breeds (Scott Dindot and Cole
McQueen- personal communication), therefore variation unique to the

Thoroughbred is likely included in this group of CNVs. Three of the mare’s CNVs

were inherited only by the foals that developed CSM (Table 4.7). Current annotation
of these loci is limited to genes encoding uncharacterized proteins.

Several studies have identified the occurrence of osteochondrosis (OC) in

cervical vertebrae of horses affected by CSM (Mayhew et al, 1978; Stewart et al,

1991; Chapter 3). OC is another multifactorial musculoskeletal disease where the
role of genetic determinants has been examined in various horse breeds (Distl,

2013 ; Corbin et al., 2011, Wittwer et al., 2007; Dierks et al., 2010; Felicetti et al.,
2009; Lampe et al., 2009). Multiple loci have been identified across the genome
with significant association to the OC phenotype. Given that many pathological
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lesions in the articular joints of cervical vertebrae of CSM horses are OC, the

previously published SNPs from the GWAS studies of equine OC were compared to

loci found in the current CSM analysis. No concordance between regions of interest
of the two diseases was found.

Given limitations in the number of CSM samples evaluated, an important

point to consider in the current dataset is statistical power. While sufficient horses
were analyzed to detect a trait regulated by a single gene with a recessive mode of

inheritance, as clearly demonstrated with chestnut coat color, the assembled sample
set may not be sufficient to resolve complex genetic determinants for CSM. When

investigating complex genetic traits in genome wide studies, a larger sample size is
required for sufficient power to identify variants that individually have a smaller

effect. In this study, a larger general population data set was used for the control
group in an effort to more confidently establish SNP frequencies in the

Thoroughbred for comparison to the CSM samples. Also, it is important to note that
the general population Thoroughbreds used for controls were genotyped for

reasons unrelated to CSM. As such, we cannot be sure that all of these horses were

free of neurological deficits. Any horses with CSM in the control population sample
set would also diminish statistical power.

Analysis in this study combined SNPs from two commercial Illumina

platforms, the 50K and 70K equine chips. Therefore, it is possible there may be a
chip bias. The PCA plot demonstrated decent overlay of the 50K and 70K horses
indicating bias might be less of an issue. That being said, some of the significant
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haplotypes in the sliding window analysis were heavily represented on one chip
versus the other making them less convincing compared to other identified loci.

Haplotypes identified in the sliding window analysis distributed on samples from
both chips include ECA 6, 27, and X. giving these regions support and priority for
further validation and investigation.

In addition to sample size contributing to lack of power, a smaller number of

SNPs was evaluated since only those common to both chips were used. One method

to address this issue would be imputation. Imputation gives the probability of a SNP
at an ungenotyped location based on the LD of the variants surrounding it. An

imputation mechanism for the 50K and 70K Equine Bead Chips has been put forth in
the literature (McCoy et al., 2013). This method would allow for evaluation of all

horses in the sample set at approximately ~65,000 SNPs before filtering versus the

~33,000 SNPS analyzed currently. Increasing the number of SNPs evaluated allows
for denser coverage of the genome and would facilitate locating significant variants
that contribute to CSM.

Additional studies will enable further refinement of loci identified in this

work. First, a new and independent population of CSM and control horses is needed
for validation of these regions. Another issue that may be critically important is
refinement of phenotyping parameters. In other words, CSM could represent a

common clinical syndrome that results from more than one pathogenic mechanism.

The anatomical structures of the vertebrae that can participate in canal stenosis are
variable (i.e. articular processes, vertebral body subluxation, epiphyseal flaring, or
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extension of the dorsal lamina). As such, it may be better to assess each type of

vertebral malformations independently by assembling CSM sample sets based on

specific vertebral malformations. Attempts to define phenotypic subcategories with
the current sample set did not improve GWAS resolution, likely because this

subgrouping further reduced the number of CSM cases available for comparison.

This is the first study to investigate the role of inherited genetic determinants

in equine CSM using a genome-wide analysis of gDNA polymorphisms. Data support
the contribution of genetic determinants to the development of disease. Control of
the CSM phenotype by one major gene is improbable, as multiple significant loci
were identified across the genome. Therefore, it is likely instead that CSM is a

complex genetic trait with the phenotype influenced by multiple genes and several
environmental variables. Subsequent studies validating loci and investigating the
role of these variants and any other contributing factors is warranted. Also, the

interaction of genetic and environmental variables is an additional investigative

point for consideration in future efforts to elucidate the etiology and pathogenesis of
CSM.

Copyright © Jennifer Gail Janes 2014
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Chapter 5
Reflections and Looking Ahead to Future Studies
Reflections
Research efforts in this dissertation thesis were aimed at examining

important questions related to the etiology and pathogenesis of equine CSM. The
specific objectives were: 1) compare the ability of MRI and standing cervical

radiographs to detect and localize cervical vertebral canal stenosis in CSM horses, 2)
evaluate the frequency and severity of skeletal lesions identified by MRI in the

articular processes of cervical vertebrae in CSM horses, 3) characterize the lesions
in articular processes of CSM horses on structural and histological levels, and 4)
investigate the role of inherited genetic determinants in CSM.

CSM remains a major problem in various equine breeds including

Thoroughbreds, Warmbloods, and Tennessee Walking Horses to name a few. Since

CSM often results in substantial neurologic deficits, it has a significant impact on the
welfare of the horse. Justification for the re-examination of CSM etiology and

pathogenesis in the context of my PhD dissertation are three-fold. First, these issues
are of fundamental importance for efforts to improve the diagnosis, management,

and/or treatment of this disease. In other words, research on these issues has the

potential to have a near-term, real-world impact. Second, technological advances in

equine science have been achieved in recent years in areas related to diagnostic
imaging and genomics. Working with these technologies provided a valuable

educational opportunity for me and increased the potential that the research would
yield results with a positive impact for horses. Finally, this dissertation research
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focus has allowed me the opportunity to advance my interests in anatomic

pathology and the equine musculoskeletal system while achieving the primary

educational goal of PhD level training in experimental biology. The project has

provided direct synergy of my educational priorities to continue to develop as a
veterinarian pursuing clinical diagnostic and discovery science interests.

In chapter 2, the hypothesis was tested that MRI is superior to standing

cervical radiographs for identification and localization of canal stenosis. It was felt
MRI could potentially improve the specificity and sensitivity of stenosis diagnostic
assessment given the ability to obtain multiple views of the cervical column as

compared to standing cervical radiography. The morphometric assessment of the
vertebral column on MRI identified canal area and the cord to canal area ratio as
useful metrics for determination of compression. Indeed, when compared to
standing cervical ratios, both canal area and CCAR on MRI demonstrated an

improvement in spinal cord compression localization. The data supported the

hypothesis originally put forth. There are limitations of this study that need to be
addressed in further studies. First, canal area and CCAR need to be evaluated in

both the extended and flexed neck position. Our study was limited to the neutral
position. On myelography, it has been demonstrated that there are cases where

cord compression is only visualized in the extended or flexed position. Secondly,

additional horses need to be evaluated to enable the establishment of thresholds for
stenosis in a clinical setting. With increased numbers and statistical power, a

Receiver Operating Characteristic (ROC) curve could be constructed to determine
sensitivity and specificity and identification of possible cutoffs for each vertebral
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site. The establishment of thresholds for canal area and CCAR would allow for
application in the diagnostic setting as technology continues to evolve to
accommodate imaging of the equine cervical column antemortem.

Experiments reported in chapter 3 use this same MRI primary dataset to

evaluate bone and cartilage pathology in the articular processes of CSM horses. The
study quantified an increased number and severity of lesions relative to controls,

followed by histological and microstructural assessments of pathological changes in
the lesions. The findings support a generalized bone and cartilage developmental
issue of the cervical column, in which pathology is not limited to only the site of

compression in horses with CSM. A subset of lesions evaluated structurally and/or
histologically found osteochondrosis, osseous cyst-like structures, fibrous tissue

replacement of trabecular bone and bone marrow, and osteosclerosis. The data are
consistent with primary skeletal developmental issues, associated with secondary
biomechanical stresses on the vertebral column leading to CSM pathology in the

articular processes. It is important to note that growth plates in equine vertebrae

do not close until 4-5 years of age, so CSM normally develops and becomes clinically

apparent while horses are still very much in a phase of growth and maturation.

Prior to growth cessation, the vertebrae are likely more responsive to the abnormal
biomechanical forces.

Analyses of the pathological lesions have provided important new

information about equine CSM. Most notably, these include pathologic lesions

identified regardless of compression site and descriptions of novel osseous cyst-like
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lesions present in the articular processes. Further studies are needed to determine
if similar pathology is observed in other parts of the vertebrae and appendicular

skeleton. If this occurs, it would further support a generalized defect in bone and
cartilage morphogenesis and/or maturation.

The long-standing question that probably generates the most interest among

equine veterinarians and horse owners is the extent to which inherited genetic
determinants are an important variable in the etiology, pathogenesis, and/or
susceptibility of horses to this disease. It really is an important issue to re-

investigate, given that the entire equine genome has now been sequenced and

related genomic DNA analytical reagents are now available. The hypothesis tested
was that there are inherited genetic determinants that contribute to the

susceptibility of CSM in the horse. A genome wide association study (GWAS) using
single nucleotide polymorphisms (SNPs) and haplotypes was performed. Multiple
significant loci associating with the CSM phenotype were identified across the

genome supporting the role of genetic determinants in clinical disease. Control of

CSM by a single gene consistent with a simple Mendelian trait is unlikely given the

results of this study. Instead, the identification of multiple loci supports a complex
trait. Complex traits are influenced by multiple genes and the phenotype does not
follow simple Mendelian patterns of inheritance. Many complex traits are also

regulated by environmental variables. Findings from the current work are generally
consistent with earlier research from other groups, indicating that equine CSM is a

multi-factorial disease. Importantly, these data can also serve as a starting point for
continued investigation of genetic determinants associated with CSM. Validation of
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the identified loci using a new and independent sample set is needed as studies
move forward. An important point to keep in mind for experimental design of

subsequent analyses is sample phenotyping. There are different anatomical ways to
achieve cord compression that should be considered for subgrouping of samples for
testing. Different combinations of genotypes could control the various anatomic
phenotypes. Comparison of genotypes across the types of compression would
identify if there were genetic heterogeneity associated with CSM as well.

Experiments in this dissertation provide support for the role of genetic

determinants in CSM. The next logical step is fine mapping of validated regions with
either a high density SNP array or targeted genome sequencing for further

refinement. This would allow for identification of strong candidate genes. Another
approach is the use of whole genome sequencing of a family with multiple affected
individuals, such as the family described in chapter 4. The cost of whole genome

sequencing has fallen in recent years making it potentially feasible for studies with

smaller sample sets. It would allow for identification of multiple variants in protein
coding genes and regulatory elements. There are logistical considerations that

would need to be considered with whole genome sequencing such as cost, number
of animals, and mechanisms to confidently identify variants associated with the
disease phenotype. However, if possible it could be a powerful tool for further
refinement of the role of genetic determinants in CSM.

Although establishment of equine CSM as a multi-factorial disease makes

issues related to etiology, pathogenesis, and susceptibility more complex, it also
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identifies important strategies for research going forward. One example would be
to search for epigenomic factors. Epigenetics is the field of science that focuses on
changes in gene expression without alterations in the DNA nucleotide sequence.

Multiple studies have confirmed alterations in environmental factors, specifically

nutrition, can lead to epigenetic modifications affecting disease susceptibility (Wolff
et al., 1998; Waterland et al., 2003). Also, it has also been demonstrated that

epigenetic signatures can be inherited (Jirtle and Skinner, 2007). By investigating

the interaction between environmental and genetic variables in equine CSM, it could
provide valuable new insights about this disease.

Given the evidence that developmental issues of bone and cartilage

morphogenesis and/or maturation have an important role in CSM pathogenesis,

investigation of the cervical column during gestation and the early postnatal period
will almost certainly be of value. There have been reports of subclinical stages of
osteochondrosis in late gestation (Olstad et al., 2011). It is possible that

predisposition for vertebral malformation could begin in utero. Identification of
critical time points of cervical vertebral development would be useful for

establishing windows when the vertebrae are susceptible to influences leading to
malformations.

The obvious clinical relevance of continuing to address factors implicated in

the etiology and pathogenesis of CSM is improved diagnosis, management,

treatment, and even possibly prevention of the disease. Work in this dissertation

supports a role of genetic determinants as an etiologic factor in equine CSM. Future
98

studies need to confirm the identity of important loci and specifically define

contributing genetic factors. This will enable genetic risk scores for application to
management practices and breeding decisions to be developed. Likewise, further

understanding of the cervical vertebral column development could identify critical

time points for optimal implementation of disease modifying management practices.
Pulling Together our Current Understanding of Equine CSM

Organizing published literature and the work from this thesis, it is possible to

summarize factors that confer an increased or decreased risk of developing CSM
(Figure 5.1) and pathological changes observed with the disease (Figure 5.2).
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Figure 5.1: Risk factors for cervical stenotic myelopathy (CSM). A variety of factors
are known or believed to contribute to clinical development of CSM. Factors listed
on the left side are associated with a decrease risk of disease, while factors on the
right in a combinatorial manner increase disease incidence.
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Figure 5.2: Vertebral gross and histopathologic changes associated with CSM. Each
box represents a particular anatomical structure with listed gross and/or
histopathologic lesions that have been identified with this disease. It is important to
note that while these changes can be seen individually, it is also common to see
combinations of lesions.
It is much more challenging to develop a working model of CSM etiology and

pathogenesis. There are multiple ways to achieve spinal canal stenosis; some paths

are straightforward while others are likely complex. A simple path to canal stenosis
and cord compression would be a horse experiencing a traumatic event that results
in a cervical vertebral subluxation. Another relatively straightforward example

might be a horse developing epiphysitis and flaring of the vertebral growth plates.
Other pathways, however, will clearly be more complex.
101

Given the strong evidence that development, growth, and maturation of

cervical vertebrae are important variables, consideration of a timeline should be
helpful (Figure 5.3). The figure illustrates important events and time periods in

comparison to age of CSM diagnosis for 252 Thoroughbred cases. Genotype of an

individual is defined at conception. Skeletal ossification in the equine fetus begins
around gestational day 37 (Jenner et al., 2014). By 2 years of age, Thoroughbreds
have attained approximately 95% of their final height and 90% of the their final
body weight (Kocher and Staniar, 2013). Closure of the vertebral growth plates
occurs between 4-6 years of age (Whitwell and Dyson, 1994, Stephen Reed -

personal communication). Osteochondrosis (OC) is generally reported to develop

between birth and 5 months of age (Carlson et al., 1995; Dik et al., 1999; van Weeren,
2006), but recent work is also considering cartilage biology in utero (Olstad et al.,
2011). Environmental variables are relevant throughout these periods.
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Figure 5.3: Skeletal growth and maturation timeline in the context of variables and
pathology associated with CSM. The timeline is presented from conception to 6
years of age. Above the timeline, pertinent points related to general skeletal and
vertebral growth are indicated. Below the timeline, the influence of proposed
etiology factors are depicted. A survey of the age at CSM clinical diagnosis for
Thoroughbreds scaled to match the timeline is at the bottom.
CSM remains an important neurologic and musculoskeletal disease of the

horse and therefore warrants continued research for further understanding of

disease mechanisms. With discovery science, the investigation of relevant questions
often results in generating more questions. This dissertation thesis is no different.
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Rapid advances in genomics, diagnostic imaging, and molecular technologies allow
for continued investigation and hopefully relevant contributions to the
understanding of CSM.

Copyright © Jennifer Gail Janes 2014
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